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Research Needs for the Risk Assessment
of Health and Environmental Effects
of Endocrine Disruptors: A Report
of the U.S. EPA-sponsored Workshop
Robert J. Kavlock,1 George R Daston,2 Chris DeRosa,3 Penny
Fenner-Crisp,4 L. Earl Gray,1 Steve Kaattari,5 George Lucier,6
Michael Luster,6 Michael J. Mac,7 Carol Maczka,8 Ron Miller,9
Jack Moore,10 Rosalind Rolland,"1 Geoffrey Scott,12 Daniel
M. Sheehan,13 Thomas Sinks,14 and Hugh A. Tilson1
The hypothesis has been put forward that humans and wildlife species have suffered adverse
health effects after exposure to endocrine-disrupting chemicals. Reported adverse effects include
declines in populations, increases in cancers, and reduced reproductive function. The U.S.
Environmental Protection Agency sponsored a workshop in April 1995 to bring together interest-
ed parties in an effort to identify research gaps related to this hypothesis and to establish priori-
ties for future research activities. Approximately 90 invited participants were organized into work
groups developed around the principal reported health effects-carcinogenesis, reproductive toxi-
city, neurotoxicity, and immunotoxicity-as well as along the risk assessment paradigm-hazard
identification, dose-response assessment, exposure assessment, and risk characterization.
Attention focused on both ecological and human health effects. In general, the group felt that the
hypothesis warranted a concerted research effort to evaluate its validity and that research should
focus primarily on effects on development of reproductive capability, on improved exposure
assessment, and on the effects of mixtures. This report summarizes the discussions of the work
groups and details the recommendations for additional research. Environ Health Perspect
1 04(Suppl 4):715-740 (1996)
Key words: endocrine disruptors, hormones, risk assessment, carcinogenesis, reproductive
toxicity, developmental toxicity, immunotoxicity, neurotoxicity, exposure assessment,
research needs
Introduction
Evidence has been accumulating which
indicates that humans and domestic and
wildlife species have suffered adverse health
consequences from exposure to environ-
mental chemicals that interact with the
endocrine system (e.g., 1-3). To date,
these health problems have been identified
primarily in domestic or wildlife species
with relatively high exposures to organo-
chlorine compounds, including 1,1,1-
trichloro-2,2-bis(p-chlorophenyl)ethane
(DDT) and its metabolites, polychlorinat-
ed biphenyls (PCBs) and dioxins, or to
naturally occurring plant estrogens. It is
not known if similar effects are occurring
in the general human population, but
again there is evidence of adverse effects in
populations with relatively high exposures.
Several reports (4) of declines in the quali-
ty and decreases in the quantity of sperm
production in humans over the last four
decades and reported increases in inci-
dences of certain cancers (breast, prostate,
testicular) that may have an endocrine-
related basis have led to speculation about
environmental etiologies. However, con-
siderable scientific uncertainty remains
regarding the causes of these reported
effects. Nevertheless, it is known that the
normal functions of all organ systems are
regulated by endocrine factors, and small
disturbances in endocrine function, especial-
ly during certain stages of the life cycle such
as development, pregnancy, and lactation,
can lead to profound and lasting effects.
The critical issue is whether sufficiently high
levels of endocrine-disrupting chemicals exist
in the ambient environment to exert adverse
health effects on the general population.
Current methodologies for assessing
human and wildlife health effects (e.g., the
generation of data in accordance with test-
ing guidelines developed by the U.S.
Environmental Protection Agency [U.S.
EPA]) are generally targeted at detecting
effects rather than mechanisms, and may
not adequately evaluate effects on the
endocrine system. This is particularly true
for exposures that occur during critical
developmental periods when the endocrine
system plays a key role in regulating essen-
tial physiological and morphological
processes. Given the potential scope of the
problem, the possibility of serious adverse
effects on the health of human and wildlife
populations, and the broad occurrence and
persistence of some endocrine-disrupting
agents in the environment, it is important
to focus the available resources for research
on the most critical gaps in our knowledge
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base so that more informed regulatory and
public health decisions can be made in the
future. The broad nature of the problem
necessitates a coordinated effort on both
the national and the international levels.
The National Science and Technology
Council, which advises the president and his
Cabinet on directions for federal research
and development efforts, has established a
milestone for 1995 to 1998 to produce a
national research strategy on endocrine-dis-
rupting chemicals. Therefore, in response to
the growing public health concerns related
to chemicals in the environment that have
the potential to act as endocrine disruptors,
the Office of Research and Development of
the U.S. EPA held a workshop on April
10-13, 1995, in Raleigh, North Carolina,
to begin developing a national research
strategy related to endocrine-disrupting
chemicals. An organizing committee was
formed that consisted of representatives
from various organizations, including the
U.S. EPA, Department of Health and
Human Services, Department of the
Interior, Department of Commerce, and
Department of Agriculture; industrial
groups such as the Chemical Manufacturers
Association and the American Industrial
Health Council; independent organizations
such as the Institute for Evaluating Health
Risks; and public interest groups such
as the World Wildlife Fund and the
Environmental Defense Fund.
The premise of the workshop was as
follows: because environmental endocrine
disruptors have caused a variety of adverse
biological effects in wildlife species, domes-
tic animals, and humans, we need to iden-
tify specific research that would assist the
federal government in making informed
decisions. An environmental endocrine
disruptor was broadly defined as "an exoge-
nous agent that interferes with the produc-
tion, release, transport, metabolism, bind-
ing, action or elimination of natural hor-
mones in the body responsible for the
maintenance of homeostasis and the regu-
lation of developmental processes." This
definition reflects a growing awareness that
the issue of endocrine disruptors in the
environment extends considerably beyond
that of exogenous estrogens and includes
antiandrogens and agents that act on other
components of the endocrine system such
as the thyroid and pituitary glands.
Approximately 90 invited participants and
members of the organizing committee
(Table 1) were asked to discuss research
needs related to the principal adverse
health effects reported for endocrine
disruptors (carcinogenesis, reproductive
[including developmental] toxicity,
immunotoxicity, and neurotoxicity) as well
as research to improve specific components
of the risk assessment paradigm (hazard
identification, dose-response assessment,
exposure assessment, and risk characteriza-
tion). Attention focused on both ecological
and human health effects. A series of ques-
tions was posed to each group to help
guide the discussions. More than 200
observers from academia, industry, govern-
mental organizations, public interest
groups, and the press also attended the
workshop. This report summarizes the
major findings of each discussion group.
Dr. Lynn Goldman, Assistant Adminis-
trator, Office of Prevention, Pesticides and
Toxic Substances (OPPTS), U.S. EPA,
opened the workshop. She reviewed the
impact of the National Performance
Review on environmental protection, the
process of updating the OPPTS testing
guidelines, and some regulatory activities
related to endocrine disruptors (e.g., the
special review of triazines, an evaluation
of endosulfan, and the status of the
alkylphenol ethoxylate consent order). Her
presentation emphasized the need to
address the major scientific and policy
questions as the foundation for mitigating
the potential impact of endocrine disrup-
tors. Dr. Howard Bern (University of
California at Berkeley) gave the keynote
address. This historical perspective was
based largely on the human diethylstilbes-
trol (DES) syndrome and on the neonatal
mouse model used in its experimental
analysis. He emphasized long-term perma-
nent effects in the adult as a result of expo-
sure to agents during development, which
can occur without apparent birth defects in
the neonate. Dr. Bern also emphasized the
concept of critical periods for epigenetic
effects on different targets and indicated
the wide range of organs and physiological
systems that may be affected-reproductive,
endocrine, immune, neural, behavioral,
metabolic, skeletal, etc. The particular sen-
sitivity of systems to endocrine-disrupting
agents during development implies that
embryonic, fetal, and neonatal tissues may
"see" estrogens, estrogen-mimics, and other
endocrine disruptors in a different way
(perhaps even by different mechanisms)
than adult tissues. As a final prelude to the
discussions, representatives from Germany
(Dr. Andreas Gies, Umwelt Bundes Amt),
the United Kingdom (Dr. Linda Smith,
Department of the Environment), and
Denmark (Dr. Jorma Toppari, University
of Turku, Turku, Finland, on behalf of the
Danish Ministry of Environment and
Energy and the Danish Environmental
Protection Agency) presented summaries of
research needs identified by their respective
governments in recent workshops (4-6).
General Comments
from the Work Groups
Each work group consisted of individuals
with various backgrounds including field
ecology, epidemiology, basic sciences, ani-
mal and human toxicology, exposure
assessment, and risk assessment. This mix
of experts was perceived as a great advan-
tage in enhancing the groups' ability to
look at the overall problem, stimulating
establishment of common priorities, and
identifying new solutions to existing
methodologic issues. An interdisciplinary
approach should be maintained in any fol-
low-up action to this workshop. Consistent
with the interdisciplinary approach, it is
important that methods and results found
in one research arena be applied to other
research arenas. Basic research (e.g., mech-
anistic discoveries in cancer etiology)
should be applied to observational research
(e.g., use of DNA polymorphisms in epi-
demiological or field ecology studies) and
vice versa (e.g., identification of the mecha-
nisms by which DES increases clear-cell
carcinoma of the vagina in women). Sound
scientific information must be the basis of
good decision making. We should be care-
ful not to overinterpret study results when
the basic scientific techniques have not
been standardized or validated. The use of
biologic measurements requires an under-
standing of good laboratory practices
(QA/QC), reproducibility, accuracy, statis-
tical power, and replicability. In addition,
interpretation that some measurements are
predictive of adverse biological effects
requires validation studies. Finally, the
underlying issue of dose response must
always be considered when results observed
over a limited dose range are evaluated .
Many of the gaps in our understanding
of dose-response relationships for endocrine
disruptors are the same as those that have
led to much uncertainty and associated con-
troversy arising from using default assump-
tions made by regulatory agencies in the risk
assessment process. The validity of assump-
tions used in risk assessments is frequently
challenged when high-dose data in experi-
mental systems are used to estimate effects
at much lower doses in humans. Our grow-
ing analytical ability to detect chemicals at
continually lower concentrations, coupled
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Table 1. Work group participants and assignments.
Participanta Affiliationb Groupc
Mel Anderson
Gerald Ankleya
Christopher J. Bayne
David Bellinger
Howard A. Bern
Linda Birnbaum
Aaron Blair
Joanna Burger
Cynthia Carey
Janice E. Chambers
Robert E. Chapin
James R. Clarka
Theodora Colborna
Rory Conolly
Jon Cook
Ralph Cooper
John Couch
David Crews
Sally Darney
George Dastona
William P. Davis
Chris DeRosaa
Penelope Fenner-Crisp
Warren Foster
Michel Fournier
Glen Fox
D. Michael Fry
Michael A. Gallo
David Gaylor
Ellen Goldey
Tom Goldsworthy
Jay Gooch
L. Earl Gray Jra
Louis J. Guillette
Maureen C. Hatch
Jerry D. Hendricks
Andrew G. Hendrickx
Diane Henshel
David E. Hinton
Mike Holsapple
Claude L. Hughes Jr
Lyndal Johnson
Rod Johnson
Steven L. Kaattari
William Kelce
Carole Kimmel
ICF Kaiser
U.S. EPA
Oregon State University
Boston's Children's Hospital
University of California-Berkeley
U.S. EPA
NCI
Rutgers University
University of Colorado
Mississipi State University
NIEHS
Exxon Biomedical Sciences
World Wildlife Fund
Chemical Industry Institute of Toxicology
Dupont-Haskell Laboratory
U.S. EPA
U.S. EPA
University of Texas at Austin
U.S. EPA
The Procter and Gamble Co.
U.S. EPA
ATSDR
U.S. EPA
Environmental Health Canada
Universite du Quebec a Montreal
CWS, Environment Canada
University of California-Davis
Robert Wood Johnson Medical School
NCTR
U.S.EPA
Chemical Industry Institute of Toxicology
The Procter and Gamble Co.
U.S. EPA
University of Florida-Gainesville
Mt. Sinai School of Medicine
Oregon State University
University of California-Davis
Indiana University
University of California-Davis
DOW Chemical Co.
Wake Forest University
Northwest Fisheries Science Center
U.S. EPA
ViMS, College of William and Mary
U.S. EPA
U.S. EPA
C,DR
R,HD
1,DR
N,DR
R,HD
C,EX
C,HD
N,HD
l,EX
N,HD
R,RC
R,RC
l,EX
C,DR
C,HD
N,HD
C,HD
N,RC
R,RC
Rt,DR
R,EX
C,EXt
C,RCt
R,RC
O,DR
l,EX
R,HD
RC
N,RC
N,HD
C,DR
R,HD
R,HDt
R,HD
R,EX
C,HD
R,RC
N,DR
C,EX
1,RC
R,DR
R,RC
C,RC
It,RC
R,HD
R,RC
Participanta
Garet Lahivs
Coral A. Lamartiniere
John F. Leatherland
Jonathan J. Li
George Luciera
Mike Luster
Michael J. Maca
Neil J. MacLusky
Carol Maczka
Peter Mathiessen
Lynne F. McGrath
John McLachlan
Sue McMastera
Mark S. Meyers
Diane Miller
Ron R. Millera
John A. Moorea
Larry L. Needham
Reynaldo Patino
Richard E. Peterson
Warren P. Porter
Christopher J. Portier
Walter Rogan
Rosalind M. Rollanda
Louise M. Ryan
Geoffrey I. Scotta
R. Woodrow Setzer
Daniel M. Sheehana
Barbara B Sherwin
Ellen K. Silbergelda
Thomas Sinksa
Ralph Smialowicz
George Stancel
John J. Stegemen
Peter Thomas
Donald Tillitt
Hugh Tilson
Jorma Toppari
Kamala Tripathia
Daniel A. Vallero
Frederick S. Vom Saal
Chris Waller
Patricia Whitten
Elizabeth Wilson
Judith T. Zelikoff
Affiliationb Groupc
University of Maryland-Baltimore
University of Alabama-Birmingham
University of Guelph
University of Kansas Medical Center
NIEHS
NIEHS
National Biological Service
The Toronto Hospital
National Research Council
MAFF, United Kingdom
Hoechst-Celanese
Tulane University
U.S. EPA
Northwest Fisheries Science Center
U.S. EPA
DOW Chemical Co.
IEHR
CDC
National Biological Service
University of Wisonsin-Madison
University of Wisconsin-Madison
NIEHS
NIEHS
World Wildlife Fund
Harvard University
National Marine Fisheries Service
U.S. EPA
NCTR/FDA
McGill University
University of Maryland-Baltimore
CDC
U.S. EPA
University of Texas Medical School
Woods Hole Oceanographic Institute
University of Texas at Austin
National Biological Service
U.S. EPA
University of Turku, Finland
USDA
U.S. EPA
University of Missouri-Columbia
U.S. EPA
Emory University
University of North Carolina-CH
New York University Medical Center
aOrganizing committee members (Dick Hill, U.S. EPA, and Jim Reisa, NRC, were unable to attend). bATSDR, Agency for Toxic Substances and Drug Reserch; CDC, Centers for
Disease Control; CWS, Canadian Wildlife Service; FDA, Food and Drug Administration; ICF Kaiser; MAFF, Ministry of Agriculture, Fisheries and Food (United Kingdom); NCI,
National Cancer Institute; NCTR, National Center for Toxicological Research; NIEHS, National Institute of Environmental Health Sciences; U.S. EPA, U.S. Environmental
Protection Agency. CC, carcinogenic effects, R, reproductive effects; N, neurological effects; immunological effects; H D, hazard detection methods; DR, dose-response meth-
ods; EX, exposure methods; RC, risk characterization methods; t, chairperson; t rapporteur.
with the availability of molecular approaches
to detect chemical interactions with biologi-
cal systems, is creating opportunities and
more tractable approaches to improve low-
dose risk estimates. Yet considerable work
remains to be done at the laboratory and
science policy levels before there is wide-
spread acceptance of mechanistic data in
quantitative risk assessments. We need to
improve the use of existing data and to have
better data and predictive models to
strengthen the scientific foundation for esti-
mating dose-response relationships for
endocrine disruptors.
Several considerations are essential to
the examination of the effects of potential
endocrine disruptors. First is the consid-
eration of the different sensitivities at
different ages. In general, the developing
organism is especially sensitive, for exam-
ple, DES induction of adenocarcinoma of
the vagina in females exposed before the
end of the first trimester of their mother's
pregnancy. The second consideration is a
direct consequence of the first. Because the
work group recognized the importance of
the developmental stage at exposure, expo-
sure assessment as defined by the National
Research Council (7) was modified (change
noted in italics) to read: "the process of
measuring or estimating the intensity,
frequency, duration, and the timing ofexpo-
sure, of humans and wildlife to an agent
currently present in the environment or of
estimating hypothetical exposures that
might arise from releases of new chemi-
Environmental Health Perspectives * Vol 104, Supplement 4 * August 1996
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cals." The third consideration is that adverse
effects can arise from either primary or sec-
ondary disturbances of endocrine function.
Thus, an indirect-acting endocrine disruptor
affects a systemic target organ first; these
effects in turn may influence the endocrine
system to cause secondary neurotoxicity,
reproductive toxicity, and/or immunotoxi-
city. Conversely, a direct-acting endocrine
disruptor affects the endocrine system first,
which in turn results in toxicity in other
organ systems. In some aspects it is very
difficult, if not impossible, to separate the
endocrine system from the systemic target
organs, so this distinction should be viewed
in an abstract manner. Obviously, some
chemicals can adversely affect the structure
and/or function of the systemic organs
without any endocrine system involve-
ment. Such chemicals may be considered
direct-acting target organ toxicants. These
relationships are portrayed in Figure 1.
Finally, the development of a research
agenda for endocrine disruptors should be
a national or international effort by many
agencies, not just the U.S. EPA, so that the
limited resources can be used in the most
efficient manner.
Biological Effects Issues
Carcinogenic Effects
What do we know about the carcinogenic
effects of endocrine-disrupting agents in
humans and wildIife? What are the major
clas5es ofchemicals thought to be responsi-
ble for these effects? What are the uncer-
tainties associated uith the reported effents?
Numerous field studies of teleost fishes in
localized highly contaminated areas (i.e.,
"hot spots") have shown high prevalences
of liver tumors (8-10). The predominant
risk factor that has been associated with
these liver tumors is exposure to poly-
aromatic hydrocarbons (PAHs) and to a
lesser degree, PCBs and DDT. Certain
species such as carp and fathead minnows
are more resistant, while trout are more
sensitive. There has been no indication
that the liver tumors in fish involve an
endocrine modulation mechanism. Other
than for localized areas of high contamina-
tion, field studies have shown no increasing
trends for tumors of any type in fish. The
group noted that two tumor registries for
wildlife species exist in the United States
(the Smithsonian Registry of Tumors in
Lower Animals under the direction of
Dr. John Harshbarger, and the Armed
Forces Institute of Pathology's Registry of
Comparative Pathology under the direction
Direct acting
endocrine disruptor
Direct acting target
organ toxicant
_ Indirect acting
endocrine disruptor
Figure 1. Abstract representation of the interplay
between the endocrine system and the reproductive,
neurological and immunological systems to illustrate
the complexity of determining the mode of action for
chemicals that cause adverse effects through involve-
ment of the endocrine system.
of Dr. Linda Johnson). A variety of dose-
related tumors can be produced in fish
given carcinogens under experimental
laboratory conditions (11). Again, there is
no specific evidence that the development
of these tumors involves a hormonal dis-
ruption mechanism. Estradiol and certain
hormone precursors (e.g., dehydroepi-
androsterone [DHEA]) act as promotors
after treatment of fishes with carcinogenic
substances such as aflatoxin and N-methyl-
N-nitroso-N'-nitroguanidine (MNNG).
Toxicopathic liver lesions have been associ-
ated with contaminant exposure in some
marine fish (10).
There is a paucity of carcinogenicity
data for other forms of wildlife. One study
of beluga whales in the St. Lawrence sea-
way found that approximately 50% of
dead whales examined had neoplasms, of
which about 25% were malignant (12,13).
The hypothesis that endocrine disrup-
tion can cause cancer in humans is based
on the causal association between DES
exposure of pregnant women and clear-
cell adenocarcinoma of the vagina and
cervix in their female offspring, hormone-
related risk factors for breast and uterine
cancer, and limited evidence of an asso-
ciation between body burden levels of
1, 1-dichloro-2,2-bis(p-chlorophenyl)ethyl-
ene (DDE) or PCBs and breast cancer
risk. Young women who developed cancer
of the vagina were more likely to have had
mothers who used DES during pregnancy
to avoid miscarriage than mothers who did
not use the drug (14). This finding has led
to a number of important conclusions.
First, maternal exposures during gestation
can lead to cancer in offspring, and second,
it demonstrates that a synthetic estrogen
can cause cancer. Some of the male off-
spring of women who took DES display
pseudohermaphroditism (15) and genital
malformations, including epididymal cysts,
testicular abnormalities such as small testes
and microphallus, and reduced semen
quality (16-18). Follow-up surveys of
DES-exposed male offspring, however, have
not shown impairment in fertility or sexual
function (19,20), nor is there evidence of
increased risk of testicular cancer (19).
The most common cancer among
women in the United States is breast can-
cer. A number of epidemiological studies
have examined the risk factors for breast
cancer. Identified risk factors include sever-
al that relate to hormonal activity:
decreased parity, age at first delivery, age at
menarche, age, race, and unopposed estro-
gen therapy. In addition, breast tumors can
be characterized as to their degree of estro-
gen-receptor positivity resulting in relevant
prognostic information. The evidence sup-
ports a causal relationship between female
breast cancer and hormonal activity.
A number of organochlorine pesticides
or pesticidal metabolites are found in
breast milk and human adipose tissue
(21,22). Several recent cross-sectional stud-
ies suggest a possible relationship between
levels of some organohalide residues in
human tissues and breast cancer risk,
although the observations are not entirely
consistent across studies, and no clear rela-
tionship has been established (23-30). In
general, these studies suggested that levels
ofp,p'-DDE and total PCBs were higher in
fat or serum of women who had breast
cancer than in comparison groups. The
meaning of these findings is unclear, in
part, because p,p'-DDE and the few PCB
congeners that have been tested have little
or no discernible estrogenic activity, while
the short-lived forms of DDT, o,p'-DDT
and o,p'-DDE, have only very weak estro-
genic properties. Further, a recent
case-control study with historical data
from serum DDE and PCBs conflicts with
the earlier findings (29). This study
showed no overall effect of serum residue
levels on breast cancer risk, although sub-
categorical analysis did suggest a possible
increase in risk among black women with
higher levels of serum p,p'-DDE. The
women in these studies, except those in
the study by Henderson et al. (30), were
not exposed to high levels of PCBs or
DDE and the actual differences in levels
measured between cases and controls were
not large. Studies ofwomen occupational-
ly exposed to high levels of PCBs have not
demonstrated an excess risk of breast can-
cer mortality (31,32). The results of these
studies therefore are equivocal and further
research is needed (including examination
of effects in subsequent generations from
parental exposures).
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Relatively good information exists on
cancer occurrence (incidence) and mortali-
ty in the United States over the last several
decades. The best incidence data come
from the Surveillance Epidemiology and
End Results (SEER) cancer registries that
are supported by the National Cancer
Institute (33). Cancer trend data from
1973 to 1991 show that age, race, and sex-
adjusted total cancer incidence increased
by 31% in males and 14% in females. Inci-
dence rates between 1973 and 1991 for
several hormone-sensitive tissues have
increased (female breast 24%, ovarian 4%,
testicular 41%, prostate 126%) as have sev-
eral other cancer sites: melanoma (116% in
males, 73% in females); non-Hodgkins
lymphoma (84% in males, 57% in
females); and liver (55% in males, 27% in
females). However, increases in female
breast and male prostate cancers account
for the majority of total cancer increases
experienced by women (52%) and men
(70%) during this time period. The
increases in testicular and ovarian cancer
represent only 1% of the total increase in
cancer incidence. SEER data indicate that
incidences of uterine cancer and male
breast cancer have remained constant or
declined slightly.
Cancer screening is available for breast
and prostate cancer. Recent advances in the
screening process account for some of the
reported increases in cancer incidence.
White et al. (34) reported that although
the increase in breast cancer incidence
for women 25 to 44 years of age can be
explained by screening, screening does not
entirely explain the increase for younger or
older women. Feuer and Wun (35) suggest
that screening may also account for all of
the observed increase in older women. It
has also been suggested that increased
detection of prostatic cancer is due to
increased screening for prostate-specific
antigen (PSA) (36).
Examination of the U.S. EPA database
on pesticide registration for organochlo-
rines showed no correlation of the spec-
trum of tumor types observed in laboratory
animals with the assertion that the
organochlorines are related to human
breast cancer. Organochlorines frequently
increased the incidence of liver tumors in
rats, but did not increase the incidence of
mammary tumors (P. Fenner-Crisp, person-
al communication to work group). One
subclass of herbicides, the chloro-S-triazines,
produces an earlier onset of mammary
tumors in Sprague-Dawley rats (37,38),
but there are no epidemiological studies
that suggest a relationship between expo-
sure to triazine herbicide and human breast
cancer. An examination of the National
Toxicology Program (NTP) database
involving approximately 450 animal stud-
ies showed increased incidences of mam-
mary tumors in approximately 10% of the
studies. However, based on evaluation of
chemical structures and other available
information, this subset of test substances
is not likely to be estrogenic (39). This
analysis only considered the possibility that
the chemicals were direct estrogen agonists.
It is obvious that other possible mecha-
nisms exist for induction of endocrine-
mediated tumors.
It was noted that good animal or cellu-
lar models do not yet exist for study of
some endocrine-mediated tumors (e.g., tes-
ticular), which are reported to be on the
increase in the human population, and that
such models would be useful in testing
cause-and-effect relationships.
What are the research needs related to the
detection of carcinogenic effects of
endocrine disruptors?
Most ecological field studies of cancer
incidence have been devoted to examining
fish in polluted waters. Some efforts have
been made to establish comparison popu-
lations by examining nonpolluted waters.
One study collected data that could be
used for background information (11).
There are no ongoing national surveillance
programs for tracking cancer incidence
and mortality in wildlife, but the
Smithsonian Institution does maintain a
tumor registry for fish and wildlife, and
some marine mammal populations are being
tracked for tumors (12,13). When popula-
tions of wildlife are evaluated, it is impor-
tant to establish estimates of the expected
occurrence of cancer. It is also important
to identify special populations at high risk
for cancer on the basis of high exposure or
increased susceptibility. Background data
could then be used for comparisons. Fish
have proven to be the easiest animals to
study. The occurrence of cancers in other
animals should be examined as well.
In environmental settings, certain sen-
tinel species may be useful. Sentinel species
would include wildlife, domestic animals,
or laboratory animals. The goal would be
to identify species that are susceptible to
developing cancer, easily monitored for
cancer, and likely to reflect exposure in a
single ecosystem.
Last, the evaluation of exposures should
be expanded beyond polycyclic aromatic
hydrocarbons and look at additional types
of endocrine disruptors.
The study of the relationship between
endocrine disruption and female breast
cancer in humans is an obvious priority,
not only because of the high incidence of
this disease, but also because no primary
prevention is available. Hopefully, the rela-
tionship between organochlorine exposure
and breast cancer risk will be resolved
soon, given the large number of ongoing
epidemiological studies. Hence, focus
should be placed on additional issues such
as research on other possible environmental
agents, including persistent and nonpersis-
tent (e.g., nonorganochlorine pesticides
and phthalates) environmental chemicals
that may affect the endocrine system.
We should evaluate the relationship
between exposure to endocrine disruptors
and other cancer sites, particularly prostate,
testicular, ovarian, endometrial, and thy-
roid. It is also important to evaluate can-
cers of the liver, brain, and lung, as these
cancers are frequently associated with expo-
sure to environmental hazards, although
there is no evidence that exposure to EDCs
is among the known primary risk factors
for these tumors.
Epidemiological data on exposed
human populations have proven useful for
identification of human carcinogens.
Occupational cohorts and cohorts of per-
sons with exceptionally high environmental
exposures [e.g., 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) in Seveso, Italy (40);
polychlorinated biphenyls (PBBs) in
Michigan (41); and PCBs and polychlori-
nated dibenzofurans (PCDFs) in Japan (42)
and Taiwan (43)] may be important for
establishing a dose-response relationship.
The highest priority is to identify, register,
and follow populations with documented
and quantitatively verified exposures.
There was discussion regarding the
need to include in utero exposures in stan-
dard lifetime cancer bioassays to ensure
protection of the developing offspring. The
available evidence (44-47) does not clearly
demonstrate a significant increase in sensi-
tivity or induction of tumors compared to
postnatal-only exposures. However, others
have suggested that these retrospective
comparisons are not adequate to determine
the need for such exposures with EDCs,
since that mechanism of action is under-
represented in the historical database.
Domestic animals and pets may be
useful to identify carcinogenic hazards.
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What are the highestpriority research needs
for carcinogenic effects?
The following high priority research needs
were identified:
a) A systematic comparison of endoge-
nous versus exogenous substances in terms
of biologic activity, metabolism, struc-
ture-activity relationships, etc., with an
initial focus on estrogenicity and rapid
expansion to other steroid hormones. The
exogenous estrogenic substances should
include comparisons of phytoestrogens
as well as other types of xenoestrogens in
relation to endogenous estradiol.
b) Basic research to systematically and
thoroughly evaluate species-, cellular-, and
age-dependent responses, including consid-
eration of mixtures of agonists, partial ago-
nists, and antagonists, at environmentally
relevant ratios and doses.
c) Careful evaluation of toxicity and
mechanistic end points across species, includ-
ing the determination of dose-response
relationships in relation to human risk.
d) Surveillance data on the occurrence
of tumors in wildlife species.
e) Identification and follow-up health
studies of heavily exposed wildlife and
human populations.
f) Validation and application of bio-
markers that might be useful in identifying
exposures as well as adverse outcomes
based upon mechanistic considerations.
Other additional research recommen-
dations included thorough consideration of
the importance of critical timing (i.e., win-
dows) of exposure before and after birth for
carcinogenicity end points; determination
of the role of metabolism (e.g., estradiol) in
relation to certain toxicities such as breast
cancer; identification of susceptibility fac-
tors such as polymorphisms that might
result in a predisposition to certain end
points, and assessment of structure-activity
relationships for hormonal activity.
Reproductive Effects
What do we know about the reproductive
and developmental effects of endocrine-
disrupting agents in humans and wildlife?
What are the major classes of chemicals
thought responsible for these effects? What
are the uncertainties associated with the
reported effects?
Field and laboratory studies of wildlife
populations and individuals have revealed
effects in offspring that appear to be the
result of endocrine disruption. Examples
include reproductive problems in wood
ducks from Bayou Meto, Arkansas (48);
wasting and embryonic deformities in
Great Lakes fish-eating birds (49-56);
feminization and demasculinization of
gulls (57-60); developmental effects in
Great Lakes snapping turtles (61); embry-
onic mortality and developmental dysfunc-
tion in lake trout and other salminiods in
the Great Lakes (62-64); abnormalities of
sexual development in Lake Apopka alliga-
tors (65,66); reproductive failure in mink
from the Great Lakes area (67); and repro-
ductive impairment in the Florida Panther
(68). In each case, detectable concentra-
tions of chemicals with known endocrine-
disrupting effects have been reported in the
animals or in their environment, but an
etiological link has been established for
only a few of these observations. In ecolog-
ical studies, these effects were not recog-
nized until the populations began to
decline. However, the observation that a
population is stable is not an assurance that
endocrine-disrupting chemicals are not
affecting reproduction, development,
and/or growth of individuals.
In humans, there is evidence of adverse
reproductive outcomes in the DES sons
and daughters (see "Carcinogenic Effects" )
and in male offspring from the Yu-Cheng
poisoning incident (69). In adults, repro-
ductive dysfunction has been observed in
males exposed to kepone (70), and the
duration of lactation has been reported to
decrease as the concentration of DDE in
the milk increases (71,72). Egeland et al.
(73) reported decreased serum testosterone
and increased luteinizing hormone (LH)
levels in workers exposed to dioxin. There
also have been reports of declining sperm
quality in males over the last several decades
(74,75), but the etiology is far from certain.
The most convincing evidence for a gener-
al decline in male reproductive health
in humans is the increase in testicular can-
cers noted over the recent past in several
Western countries (5). Again, the contri-
bution of environmental contaminants to
this increased rate is unknown.
Further information on reproductive
effects of endocrine-disrupting chemicals
can be found in Colborn and Clement (1),
Adams (2), Medical Research Council (4),
Danish Environmental Protection Agency
(5), Umweltbudesamt (6), McArthur et al.
(76), Hoffman (77), Kihlstrom et al. (78),
Colborn et al. (79), Jansen et al. (80),
Jobling and Sumpter (81), Kelce et al.
(82), Patnode and Curtis (83), Bergeron et
al. (84), Guillette (85), Baldwin et al.
(86), Dodson and Hanazato (87), Rolland
et al. (88), and Kelce et al. (89). There are
multiple targets for these chemicals, and
effects are organ- and life stage-specific.
Still other reports contain evidence of hor-
monal activity due to environmental chem-
icals without a direct link to reproductive
effects (90,91).
Translating subtle functional deficits
within individuals into population-level
effects is the real challenge and will require
better field observations and laboratory
studies to more precisely simulate field
exposures. The generalizations that can
be made are grouped into the following
categories:
a) Sensitive stages: Developmental
stages are often the most sensitive to expo-
sure. (Development in this instance is
defined as broadly as possible to include
embryonic, fetal, larval, and juvenile
stages.) There are specific critical periods of
sensitivity to endocrine disruption. These
may be quite short and there may be more
than one. Critical periods vary for differ-
ent organs and species. The unique
changes in physiology during development
may increase sensitivity to endocrine-dis-
rupting agents. Also, sensitivity may be
sexually dimorphic or distinct in expres-
sion if not sensitivity.
Effects on development can be revers-
ible because of effects on maturation or
irreversible because of effects on differentia-
tion. Often, irreversible effects on differen-
tiation have a long latency for expression.
Adult males and females are also affect-
ed by endocrine disruptors, and there may
be physiologic states in the adult (e.g., early
pregnancy) that enhance susceptibility.
Much of our knowledge of the action of
endocrine disruptors in adult humans is
derived from the use of various steroids as
pharmacologic agents.
b) Types of effects: Endocrine disrup-
tor effects vary by species and life stage at
which exposure occurs. Endocrine disrup-
tion can result in morphologic abnormali-
ties of the gonads, reproductive tract, brain,
and other organs; functional and behavioral
abnormalities; and certain malignancies
(particularly of the reproductive system or
related structures [e.g., breast]). Functional
abnormalities include decreased semen
quality, reduced numbers of sperm, infertil-
ity, disrupted estrous or menstrual cycling,
and premature menopause; behavioral
abnormalities include altered sexual behav-
ior and decreased libido. Functional and
behavioral abnormalities may occur after
developmental or adult exposure, although
the expression is likely to be different for
the various life stages.
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Circulating hormone concentrations
may be altered by effects on hormone
metabolism or steroidogenesis. There may
also be effects on cellular function in the
endocrine system or in systems that
respond to the endocrine system mediated
by toxicant interactions on different
receptor classes.
At the more fundamental levels of bio-
logical organization, i.e., at the biochemical
and cellular level, there tends to be a great
deal of similarity among vertebrate classes
due to the extreme phylogenetic conserva-
tion of hormones and hormone receptor
binding characteristics. However, at higher
levels of biological organization there may
be divergence, as hormone systems may
have different developmental functions in
different phylogenetic groups. As an exam-
ple, in the absence of androgens, the repro-
ductive tract of mammals develops into a
female phenotype, whereas birds require
estrogens to initiate the female phenotype,
and reptiles use both androgens and
estrogens for sexual differentiation.
c) Agents that act by endocrine disrup-
tion: A number of chemicals have pro-
duced abnormal development and/or
reproductive function via an endocrine
pathway in some species. It is not the pur-
pose of this report to construct an exhaus-
tive list of these. Instead this list will
include a few illustrative examples and
indicate the classes of chemicals that
appear to be of special concern. However,
not all chemicals of a given class have
similar endocrine-disrupting potential;
also, it is likely that chemicals in other
classes not mentioned may have endocrine
toxicity potential.
Examples of agents that have been
shown to alter reproductive development in
various species via an endocrine mechanism
include:
* Hormones and drugs, including DES,
progestogens, androgens, ecdysteroids
and farnesyl hormones
* Metabolic inhibitors, including
5-a-reductase inhibitors
* Pesticides, including DDT and its
metabolites, chlordecone, and vinclo-
zolin
* Phytoestrogens and mycotoxins
* Other chemicals, including dioxins and
some PCBs
These agents do not need to be persis-
tent to have an effect, particularly if the
exposure occurs during a critical develop-
mental period. Importantly, prior exposure
to persistent chemicals can result in expo-
sure during a critical window of sensitivity
even though external exposure had long
been terminated.
Several other chemical or chemical
classes (e.g., alkylphenols, some phthalates,
bisphenol A) have been shown to interfere
with some endocrine-mediated processes
in some systems, but evidence for effects
on reproductive development in vivo is
lacking. Although these examples suggest
direct involvement with steroid receptors,
nonreceptor pathways are also potentially
important targets.
Last, a discussion of hazard is not com-
plete without mentioning that it takes
some level of exposure to have an effect.
That is, there is a dose-response relation-
ship for all chemicals. It is important to
focus on those chemicals for which endo-
crine disruption is the most sensitive effect.
Agents that have other effects of concern at
lower doses can be studied and regulated
based on those other effects if they are
considered adverse.
d) Modes of action: Modes of action
include agonistic and antagonistic receptor
binding, and effects on hormone synthesis,
storage, release, transport, and clearance.
There are many receptor-mediated modes
of action, including effects on estrogen,
androgen, progesterone, thyroxine, gluco-
corticoid, and Ah receptors. Others are
likely to be identified.
In addition to direct effects on receptors,
there are instances of metabolic inhibition
and induction that affect steroidogenesis,
inhibitors of enzymes that modify hormones
(e.g., 5-o-reductase), and effects on plasma
transport proteins and neurotransmitter
levels (e.g., effects on the hypothalamic-
pituitary axis). Differences between species
may be marked, and this may be one
important source of lack of concordance
across species. Last, it will not be a simple
matter to predict the action of mixtures.
It is noteworthy that some agents inter-
act with more than one receptor type (e.g.,
estrogen, androgen, and progesterone
receptors) and that there may be multiple
mechanisms of action for a single agent,
leading to different dose-response curves
for different outcomes.
e) Species affected: In vertebrates, there
are examples of endocrine disruption from
Mammalia (including humans and labo-
ratory animals) to Pisces. Examples in
invertebrates include gastropod mollusks
(exposed to alkyltin), insects (exposed to
insect growth hormones), and crustaceans.
It is likely that other examples have yet to
be identified. Sensitivity varies by species
and population.
f) Species concordance and divergence:
As noted above, the level of concordance
between species depends on the biological
level of organization being examined. The
greatest homology tends to occur at the
most fundamental levels of organization
and less so at the level of the organism.
Knowledge of mechanisms of action and of
basic comparative endocrinology and
embryology will greatly enhance our ability
to extrapolate among species.
Although we have considerable infor-
mation on perturbations of reproductive
development as well as on direct effects on
the adult, after exposure to chemicals that
disrupt the normal functioning of the
endocrine system, there remain important
uncertainties. In particular the work group
noted the following:
a) Species-to-species extrapolation:
There is a great deal to learn about basic
aspects of comparative endocrinology and
embryology. Concerning the former, it is
known that birds rely on estrogen for sexual
differentiation, whereas mammals rely on
androgens, and reptiles utilize both estro-
gens and androgens. While mammals rely
on androgens, it is important to remember
that the androgen serves as a precursor for
estrogen, which is the effective molecule
for sexual differentiation in brain morphol-
ogy, endocrine secretion, and behavior.
Differences have also been observed in the
specificity of serum-binding proteins. It is
likely that other differences will be found
that will help explain the diverse responses
to endocrine disruptors.
In comparative toxicology, three factors
must be considered. First, there may be
pharmacokinetic differences that affect the
concentration of the active agent at the tar-
get site. Second, there may be pharmaco-
dynamic differences in the interactions of
the agent with the molecular target and
subsequent responses. Third, superimposed
on these are differences in the genetic tem-
plate across species.
b) Availability and reliability of historical
data: Historical trend data are the basis for
identifying adverse health effects by inter-
preting the extent to which the incidence
of these effects is changing and/or is associ-
ated with other time-related trends. These
data are also extremely useful in formulat-
ing hypotheses on causation. Therefore, a
robust historical database is important for
further field and epidemiological research.
However, the historical database on human
and animal reproductive end points is not
adequate for our needs. More prospective
and retrospective studies are needed on a
Environmental Health Perspectives * Vol 104, Supplement 4 * August 1996 721
KAVLOCK ET AL.
variety of reproductive parameters. Compre-
hensive evaluation of reproductive parame-
ters in highly exposed populations (for
example, sons and daughters of mothers
exposed to DES or PCBs) would be useful
to identify the most critical effects for
which historical trend data should be ana-
lyzed. Finally, statistical analysis of histori-
cal trend data should be rigorous, as pat-
terns of change may suggest potential
underlying causes (e.g., one might suspect
different causes for a single cataclysmic
decrease in sperm count versus a continuous
gradual decline).
c) Effects at low levels of exposure:
Effects at low levels of exposure may be
qualitatively different from effects at
high levels for several reasons, including
multiple mechanisms of action, each of
which takes effect at a different dose level.
Furthermore, an agent may have multiple
effects, each having a qualitatively and
quantitatively different dose-response curve.
d) Latency: It is known that develop-
mental exposure to an endocrine disruptor
can have long latency periods before
expression of an adverse effect, the hall-
mark being DES-induced vaginal adeno-
carcinoma. Efforts should be made to
establish prospective registries of highly
exposed populations, such as sons and
daughters of mothers exposed to DES, for
other latent effects, particularly breast,
endometrial, and prostate cancers, as this
group is reaching the age when problems
become more prevalent. Other latent
effects of potential concern include cardio-
vascular, premature menopause, and
altered reproductive behavior in birds and
other fauna.
e) Relevance of bioaccumulation and
biomagnification: Although it is intuitive
that materials which bioaccumulate and
biomagnify are of special concern to those
species that consume them, the relative
contribution of these processes to toxicity
is dependent on trophic level in the food
web, life stage, physiological conditions
favoring lipid mobilization (e.g., pregnan-
cy, lactation, egg laying), and reproductive
strategy. More work needs to be done
before the contribution of bioaccumulation
and biomagnification to the toxicity of a
particular agent in a particular species can
be fully appreciated.
f) Behavior of mixtures of ligands:
Additivity, synergism, and antagonism of
components of mixtures acting at the
same receptor are complicated by several
factors; for example, the interactions may
be qualitatively different depending on
the concentration and ratio of each compo-
nent of the mixture and whether they are
agonists, antagonists, or combinations. It
may be possible to construct a set of rules to
explain the behavior of any mixture, given
satisfactory knowledge of the activities and
mechanisms of action of each component
and validation of the system. This approach
limits testing to a large but finite number of
chemicals in order to characterize virtually
infinite numbers of mixture components
and concentration. This should be contrast-
ed with the impossibility of empirically test-
ing every possible mixture.
Risk assessment approaches for mix-
tures also need further refinement. In par-
ticular, the toxic equivalency factor (TEF)
approach needs improvement. A common
mechanism of action must be clearly
demonstrated before initiating the process.
When calculating TEFs, the lowest experi-
mentally measurable response of the most
appropriate effect in the most appropriate
species should be used consistently.
g) Basic research: Although much is
known about the mechanisms of develop-
mental effects of endocrine disruptors,
much more needs to be learned. Two areas
that deserve particular attention are
improved understanding of dose at the
target site and the investigation of addi-
tional potential modes of action involving
paracrine and autocrine signaling pathways.
h) Sensitive populations: Although we
are generally aware of the life stages most
sensitive to endocrine disruption, there is
still some uncertainty about the relative
sensitivity of populations. Marked differ-
ences in the responsiveness of different
inbred mouse strains to the toxicity of
TCDD suggest that there may be substan-
tial variability of response in other species,
and for other endocrine disruptors. In
wildlife populations, there is uncertainty
as to whether differences in susceptibility
of subspecies has led to a decrease in
genetic variability.
What are the research needs related to the
detection of reproductive and developmen-
tal effects ofendocrine disruptors?
While numerous wildlife and ecosystem
pollution studies have assessed reproduc-
tive end points and a few well-documented
examples of the effects of EDCs in wildlife
have been identified, little is known about
endocrine-disrupting chemical effects in
most wildlife populations. Structured
research on the status and trends of popu-
lations and communities including natural
variations is needed to detect population
changes that might not otherwise be appar-
ent until significant losses occur. The
group constructed the following list of
research needs:
a) Establishing cause and effect
relationships: Hypotheses generated from
field observations must be tested in the lab-
oratory and in controlled field studies. This
will require collection of more complete
field data on hormone levels, tissue burdens
of chemicals, and more measures of marker
expression (e.g., vitellogenin) to guide lab-
oratory studies. Existing long-term ecologi-
cal field studies should be identified that
can be integrated into the endocrine dis-
ruptor research agenda to test hypotheses.
This research must be multi-disciplinary in
nature, and improved mechanisms for
information exchange between field and
laboratory researchers must be established.
Better statistical models to predict risk
from observations of exposure and effects
are also needed.
b) Biomarkers: Better biomarkers are
needed that reflect both exposure to and
effects of endocrine disruptors. These
biomarkers need to correlate with the most
sensitive end points associated with
endocrine disruptors. These biomarkers
must address species differences, sexual
dimorphism characteristics, and be life
stage specific. They must be applied in
long-term, transgenerational studies to
identify biomarkers in offspring that can be
measured shortly after exposure and that
are predictive of long-term or latent effects.
c) Data collection: More extensive
studies are needed of both highly exposed
wildlife and human populations (for
example, sons and daughters of mothers
exposed to DES or PCBs) as well as popu-
lations exposed to a contemporary ambi-
ent level of endocrine disruptors.
Throughout these studies, researchers
must consider that there may be no unex-
posed populations. Research hypotheses
should be evaluated in these populations.
More information on normal population
variation, as well as regional and seasonal
effects, should be gathered. Both prospec-
tive and retrospective historical trend
information is required for wildlife
and human populations in order for
researchers to identify adverse reproductive
health trends (e.g., reduced semen
quality and quantity in humans, reduced
reproductive success in wildlife) and to
develop and test hypotheses about their
causation when possible.
More data on exposure monitoring
coupled with integrative bioassays of
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effects are needed, which would be facili-
tated by coordination of different agency
efforts (e.g., National Oceanographic and
Atmospheric Administration [NOAA],
U.S. Fish and Wildlife Service [USFWS],
U.S. Geological Service [USGS], National
Biological Service [NBS]). Traditionally,
exposure data have focused on adults. That
focus must shift to collecting data for the
most sensitive life stages, recognizing that
effects may have prolonged latency periods
before they are manifested.
d) Basic research: Studies on basic
developmental biology need to address the
ontogeny of receptor systems. Classical
approaches to the study of receptor-based
mechanisms may not apply to early devel-
opmental periods. Research should be
conducted to identify the end points in
multigenerational studies that are most
sensitive to endocrine disruption. Both
receptor and nonreceptor-mediated mech-
anisms of endocrine disruption should be
studied, and the normal hormonal envi-
ronment of the developing organism and
the adult must be better characterized.
Better and cheaper analytical tools need
to be developed, including molecular probes
for gene expression products, and immuno-
assays for biological tissues. Research efforts
would be greatly facilitated by establishment
of a repository of radiolabeled compounds,
antibodies, and cDNAs available at minimal
cost to researchers. Laboratory studies must
focus on low-dose exposures reflecting real-
istic environmental levels, environmental
mixtures, and pharmacokinetic parame-
ters, including modeling of nonlinear
dose-response relationships.
e) Mixtures: Because little is known
about the hazards of chemicals in environ-
mentally relevant mixtures, a scientifically
based risk assessment approach is needed to
deal with mixtures. Chemical interactions
can be very complex and need to be charac-
terized at a number of environmentally rele-
vant dose levels. The model of receptor
interaction used in these studies needs to be
carefully examined, as a single receptor can
activate a number of genes, which is a partic-
ular concern with environmental mixtures.
A toxic equivalents approach (TEQ) is
potentially useful for assessing the risk posed
by multiple chemicals with a common
mechanism of action. Validation of this
approach should consider multiple variables
such as species differences, sensitivity of the
end point(s) measured, mechanism of
action, nutritional status, co-occurrence of
infection, and doses. The most useful
approach would use the most appropriate
end point in the most appropriate life stage
of the appropriate sensitive species.
f) Screening methods: Given the need
to test many more chemicals for endocrine-
disrupting potential, short-term in vivo and
in vitro tests that are rapid, reliable, and
inexpensive must be developed to screen
chemicals for relevant hormonal activity.
Screening methods will only be useful if
they are sensitive to a variety of mecha-
nisms of action by endocrine disruption.
The most sensitive end points need to be
identified. Behavioral and growth parame-
ters are end points to explore further. A
testing approach incorporating both in
vitro and quantifiable in vivo tests that are
validated is needed. Where the mode of
action is known, research on the molecular
basis of the effect of endocrine disruptors
on gene expression is needed to identify
molecular probes reflecting the morpholog-
ic and/or functional changes in the repro-
ductive system. Where the particular
mechanism(s) of action of a compound is
unknown, more long-term in vivo assays
are needed. Early life-stage testing in
rodents, fish, and amphibians seems
promising as an in vivo screening method.
Quantitative structure-activity relationship
(QSAR) models need to be developed fur-
ther to help prioritize compounds for more
extensive testing.
g) Population heterogeneity: The
possibility needs to be studied that
endocrine-disrupting chemicals may be
decreasing the genetic variability of
populations through selection pressure.
Comparisons of liver tumor frequencies,
PAH burdens, age, and length characteris-
tics of brown bullheads collected in the
early 1980s from two tributaries of Lake
Erie strongly support the hypothesis that
the bullheads in the Black River were
subjected to an age-selective mortality asso-
ciated with a high incidence of PAH-associ-
ated liver carcinoma (8). Genetic diversity
estimates for the mitochondrial genome of
this species at these and seven other sites in
the lower Great Lakes in the late 1980s
were always much lower in populations
from the contaminated sites than in nearby
reference sites (92), apparently due to sto-
chastic reductions in population size.
What are the highestpriority research needs
for reproductive anddevelopmental effects?
Developmental and reproductive toxicity is
a problem with important implications for
public health and ecosystem health.
Research is needed to delineate the contri-
bution of endocrine-disrupting chemicals
to the observations of adverse effects on
reproduction and development in humans
and in wildlife populations. Because of the
potential long-term impacts on both indi-
viduals and populations, this area deserves
a high research priority.
Among the highest priority needs in
this area are the following:
a) Controlled laboratory tests of
hypotheses generated from field studies.
b) More extensive studies on wildlife
and human populations exposed to high
levels of endocrine-active toxicants (e.g.,
the DES and PCB cohorts) to identify the
adverse health effects most likely to occur
from developmental endocrine disruption.
c) Better definition of normal variabili-
ty in reproductive parameters and more
comprehensive temporal data (both
prospective and retrospective) so that poten-
tial trends can be identified more readily
and reliably, and hypotheses tested regard-
ing their causation.
d) Characterization of the interaction
of mixtures of endocrine-active toxicants,
and the development and validation of risk
assessment methods that adequately
account for these interactions.
e) Development of QSAR and short-
term screening approaches to identify
potential endocrine-active hazards to repro-
duction and development.
Neurological Effects
What do we know about the neurological
effects of endocrine-disrupting agents in
humans and wildlife? What are the major
classes ofchemicals thought to be responsi-
ble for these effects? What are the uncer-
tainties associated uwith the reported effects?
The work group determined that neuroen-
docrine disruption can be induced by multi-
ple mechanisms. Direct effects on endocrine
glands (e.g., the thyroid) may alter the hor-
monal milieu, which in turn can affect the
nervous system, resulting in neurotoxicity.
Conversely, EDCs may initially act on the
central nervous system (CNS) (e.g., neu-
roendocrine disruptors), which in turn can
influence the endocrine system. It was
noted that exposure to chemicals can
adversely affect the structure and function of
the nervous system without any endocrine
system involvement. The group considered
several examples of effects produced by dis-
ruption of the endocrine system and agreed
that alterations in the following would be
indicative of neuroendocrine disruption:
reproductive behaviors mediated by alter-
ations in the hypothalamic--pituitary axis
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(e.g., courtship and parental behavior in
avian species); alterations in metabolic rate,
which could indirectly affect behavior;
altered sexual differentiation in the brain,
which could affect sexually dimorphic
reproductive and nonreproductive neural
end points; and some types of neuroterato-
genic effects. The group concluded that
there were clear examples in the human
and animal literature in which exposure to
endocrine disruptors had occurred and
effects on behavior, learning and memory,
attention, sensory function, and psy-
chomotor development were observed
(60,76,79,93-110). Some of these effects,
however, can also be produced by develop-
mental neurotoxicants having little or no
known endocrine-disrupting properties
and, therefore, cannot be regarded as
specific to the endocrine-disrupting class of
chemicals. It was also pointed out that
exposure to a number of nonchemical fac-
tors (e.g., food or oxygen deprivation, infec-
tions, and temperature) could also adversely
affect the nervous system resulting in effects
similar to those produced by endocrine dis-
ruptors. These nonchemical factors may
also interact in as yet unpredictable ways
with chemical stressors. Therefore, consid-
erable care should be taken to eliminate
nonchemical causes before concluding that
neurotoxicity is causally related to the
effects of a chemical acting on the
endocrine system.
The group concluded that there were
several examples of chemicals or classes of
chemicals that produce neurotoxicity by an
endocrine mechanism. It was agreed that
environmental toxicologists should consid-
er the dose at which neuroendocrine dys-
functions are produced relative to the con-
centrations existing in the environment
and relative to dose levels at which other
toxic effects occur, the relationship between
exposure and effect, and the role of natu-
rally occurring chemicals with endocrine-
mimicking properties. With these caveats
in mind, examples of directly or indirectly
acting neuroendocrine disruptors include
some PCBs, dioxins, DDT and related
chlorinated pesticides and their metabo-
lites, some metals (methylmercury, lead,
organotins), insect growth regulators,
dithiocarbamates, synthetic steroids,
tamoxifen, phytoestrogens, and triazine
herbicides. Identification of chemicals as
neuroendocrine disruptors should be based
on mechanistic information at the cellular
or molecular level in the endocrine system
or defined functionally in terms of activity
on responses known to be mediated by or
dependent on hormones. All definitions of
neuroendocrine disruptors should be inter-
preted specifically with respect to gender,
hormonal status, and developmental stage,
since the expression of toxicities of chemi-
cals may change significantly depending on
these variables.
The group identified a number of
uncertainties critical to understanding the
significance of the effects of neuroendocrine
disruptors, including:
a) Chemicals occur as mixtures in the
environment, thereby making it difficult to
assign cause and effect for specific agents. It
is possible that the parent chemical may
not affect the endocrine system but is
metabolized to an active form. The toxico-
kinetics of and relative tissue distribution
into the nervous system are generally
unknown for most chemicals; little is
known about the metabolic interaction
between chemicals in mixtures.
b) There are ranges of possible specific
and nonspecific effects that could be mea-
sured. Research to date has used only a
small number of techniques and methods,
and it is likely that many neuroendocrine
effects may be subtle and not easily detected
with currently available procedures. It is
also a concern that the functions most sen-
sitive to chemically induced alterations in
neuroendocrine function are the most
difficult to measure in the field.
c) It is critical to know when exposure
occurred relative to when the effects are
measured. Observed effects could be depen-
dent on a number of extrinsic factors such
as seasonal variability and intrinsic factors
such as hormonal status. In addition, the
nervous system is known to be differentially
sensitive to chemical perturbation at various
stages of development. A chemical may
have a significant effect on neuroendocrine
function if exposure occurs at a critical
period of development but have little or no
effect at other stages of maturation.
d) Several issues related to extrapola-
tion are critical to understanding neuroen-
docrine disruptors. For example, it is
difficult to evaluate the significance to
human health of a chemically induced
change in a behavior that does not natural-
ly occur in humans, i.e., there are concerns
about the appropriateness of some animal
models for toxicologic studies. In addition,
there are uncertainties about extrapolating
from species to species and from experi-
ments conducted in the laboratory to those
performed in the field.
e) There are uncertainties about the
shape of the respective dose-response
curves for many neuroendocrine effects. It
is likely that some chemicals may have
multiple effects occurring at different
points on the dose-response curve.
f) The group concluded that basic
information concerning the mechanism of
action of chemicals on the developing ner-
vous system and the neurological role of
hormones during development would
greatly reduce uncertainties about risk of
exposure to neuroendocrine disruptors.
Furthermore, it is also important to under-
stand the consistency of the effects relative
to the hypothesis that chemicals are affect-
ing the nervous system.
What are the research needs related to the
detection ofneurological fects ofendocrine
disruptors?
The group considered a number of research
needs:
a) Opportunistic field studies:
Coordinated epidemiological research to
exploit human and wildlife populations,
which have known exposures to neuroen-
docrine disruptors, to define the biological
effects most likely to occur:
b) Laboratory/field studies: Systematic
field and laboratory studies that focus on
critical experimental uncertainties, e.g.,
dose-response determinations, effects of
different duration of exposures, time of
exposure during development, and age
of assessment and integration of various
end points.
c) Mixtures: Systematic research to
address the principle of additivity in deter-
mining the risk associated with exposure to
mixtures.
d) Toxicokinetics: Studies to determine
the age group-dependent toxicokinetics
and toxicodynamics of environmentally
relevant chemicals, with an emphasis on
providing better exposure assessments to
correlate biological effects with target or
tissue dose.
e) Mechanisms of action: Research at
the cellular and molecular levels to provide
a better understanding of the mechanisms
of action for known neuroendocrine
disruptors.
f) Basic research: Research to better
understand the normal development of the
nervous system and the role that endocrine
systems may play in that development.
g) Sentinel species and biomarkers:
Identification of sentinel species and devel-
opment of biomarkers of exposure and
effects for neuroendocrine disruptors.
h) Identification of sensitive subpopu-
lations: Research to determine if there are
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populations or individuals that may be
differentially sensitive to neuroendocrine
disruptors.
i) Multigeneration assay development:
Multigenerational research in both inverte-
brates and vertebrates to assess the possible
transmission of effects across generations
What are the highestpriority research needs
for neurologaleffcts?
The group agreed that research concerning
the effects of chemicals on the neuroen-
docrine system should have a relatively
high priority. Because the developing ner-
vous system is differentially sensitive to
chemicals, there is great concern that low-
level exposure to environmentally relevant
mixtures of chemicals could have subtle,
long-lasting effects on nervous system func-
tion in a number of animal and human
populations. Neurotoxicologic effects have
been documented in children exposed to a
number of environmentally relevant chemi-
cals, including the PCBs, methylmercury,
and lead (111), although these do not nec-
essarily act primarily via endocrine-mediat-
ed mechanisms. Finally, the group noted
that the nervous system interacts with or
controls other potential targets (immune
and reproductive systems) and serves as an
interface between the environment and the
internal milieu. It seems likely that effects
on other target systems and the manner in
which organisms perceive and respond to
the environment may involve the neuroen-
docrine system to some degree. Thus, stud-
ies on the mechanisms of neuroendocrine
disruption should provide crucial informa-
tion concerning mechanisms of other bio-
logical effects.
Among the highest priority research
needs in this area are
a) The initial focus on identifying and
documenting effects of concern to humans
and wildlife that are possibly mediated by
the neuroendocrine system
b) Follow-up studies to determine the
parameters of exposure to specific chemi-
cals and the time of assessment of effects
on the neuroendocrine system
c) Demonstration of biological plausi-
bility between exposure to chemicals and
observed effects in humans and wildlife
d) Studies on the potential mechanism
of action of observed effects
e) Attention to the roles of mixture in
the effects produced by neuroendocrine
disruptors
f) Better understanding of the interac-
tion of the nervous system with other
potential targets of endocrine disruptors.
Immunological Effects
What do we know about the immunologi-
cal effects ofendocrine-disrpting agents in
humans and wildlif? What are the major
claes ofchemicals thought responsiblefor
these effeets? What are the uncertainties
associaed uith the reported effects?
Published studies have demonstrated
associations between autoimmune syn-
dromes and DES exposure (112). A rela-
tionship is well established between physio-
logical estrogen levels and autoimmune dis-
eases in women (113-115). The observa-
tions that exposure of humans to DES,
TCDD, PCBs, carbamates, organo-
chlorines, organometals, and certain heavy
metals alters immune phenotypes or func-
tion are suggestive of immunosuppression
and potential disease susceptibility
(116-119). Experimental animal studies
support these observations (e.g., 120-126),
although dose-response information is
needed to clarify whether these are directly-
or indirect-acting agents. With respect to
fish and wildlife, it was also noted that sev-
eral of the agents listed above induce
immune suppression or hyperreactivity
similar to that reported in experimental
animals and humans. Embryonic exposure
of trout to aflatoxin has led to alterations
in adult immune capacity (127-129).
With regard to disease susceptibility and
exposure, there have been examples such as
the dolphin epizootic of 1987 to 1988
(130). In this case there was an association
with PCBs and DDT in the blood,
decreased immune function, and increased
incidence of infections among affected
individuals (131). Impairment in immune
function has been reported in bottlenose
dolphins exposed to PCBs and DDT (132)
and in harbor seals fed fish from polluted
waters (133,134). From 1991 to 1993,
specific immune functions and general
hematologic parameters were measured in
herring gull and Caspian tern chicks from
a number of study sites in the Great Lakes
chosen across a wide range of organochlo-
rine contamination (primarily PCBs). As
the hepatic activity of ethoxyresorufin-0-
deethylase (EROD), an index of exposure,
increased, thymus mass decreased. At high-
ly contaminated sites both gull and tern
chicks showed marked reductions in T-
cell-mediated immunity as measured by
the phytohemagglutinin skin test (135).
A variety of immunoassays have been
used to demonstrate effects in experimen-
tal laboratory animals, humans, fish, and
wildlife. These include modulation of
antibody responses (both in vivo and in
vitro), the phytohemagglutinin skin test,
mitogenesis, phagocytosis, levels of com-
plement or lack of acute phase reactants,
cytotoxic T-lymphocyte reactivity, and nat-
ural killer cell activity (136-142).
Evidence of an increased rate of
autoimmunity associated with prenatal
DES exposure suggests the possibility that
other endocrine-disrupting chemicals
(EDCs) may induce a similar pathologic
state. Studies are needed to determine if
there has been an increase in cases of
immune dysregulation in areas or sites
where EDC exposures have occurred.
Evidence indicates that the incidences of
allergy and asthma (which are forms of
hypersensitivity) are increasing in humans
(143-145). It is not known whether EDC
exposures are responsible for some part of
this development. Alteration of sex-steroid
balance has been shown to lead to increased
or accelerated onset of autoimmune syn-
dromes in mice (114). In rats and mice,
heavy metals such as lead, mercury, and
gold enhance autoimmune syndromes
(146,147). There have also been reports of
exposures of fish to EDCs in the environ-
ment that lead to immune enhancement.
Although autoantibodies have been reported
in sharks and trout (148-150), no attempts
have been made to correlate exposure to
EDCs with incidences of autoantibodies. In
trout, embryonic exposure to aflatoxin B1
can lead to immune stimulation or sup-
pression in the adult, depending upon the
immune parameter analyzed (129). Other
data suggest that small changes in physio-
logic levels of estrogens can affect the
immune system, and studies in gull and
tern chicks in the Great Lakes clearly indi-
cate that the findings are associated with
developmental exposures (135).
Concerning direct-acting EDCs,
although it would appear that these agents
directly affect the immune system, it is
unknown whether there may be disruptive
effects on the endocrine-immune axis.
Since the immune and endocrine systems
are linked via various cytokine signaling
processes (IL-1, ACTH, catecholamines,
prolactin, and endorphins), it is likely that
EDC effects on the immune system
modulate elements of the endocrine or ner-
vous systems or vice versa. Too little is
known about the dose-response curves for
immunotoxicity, neurotoxicity, or endo-
crine effects to decipher the independent or
interactive effects on these systems. Because
of the high degree of intercommunication
between these systems, there is a need for
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coordinated and cooperative studies among
laboratories in all these disciplines.
Although the most forceful arguments
for the overall consequences of immune dys-
function would be increased disease inci-
dence, this is difficult to assess in humans
or wildlife populations. Furthermore, only
certain subpopulations (the very young or
elderly) may be affected. Disease may only
be manifested as a population decline.
Disease trials can be undertaken, but they
require controlled laboratory experiments
employing populations of wild animals or
fish that can easily be maintained in the
laboratory. In humans, the variability with-
in a population makes it difficult to deci-
pher exogenously triggered effects.
The fact that employment of a variety
of in vitro assays has been successful in cor-
relative exposure studies leads to the ques-
tion of whether those immune parameters
can be correlated with the increased risk of
disease. A number of immune parameters
operate independently (i.e., lysozyme lev-
els, complement activity, phagocytosis,
induction of cytotoxic T lymphocytes,
plaque-forming cells, etc.). Which combi-
nation of these assessments would make for
an optimal predictive suite of assays?
Knowledge of normal baseline values
for wildlife species, and in most cases
humans, is lacking. If these populations are
to be screened for perturbations in immune
function, control populations must be
defined and standardized control values
obtained. Also, the types of exposures must
be well documented (i.e., dose, length of
exposure, timing).
What are the research needs related to the
detection of immunological effects of
endocrine disruptors?
The work group identified the following
research needs related to the assessment of
immunological risk to human and wildlife
populations:
a) Epidemiological analyses: Human
populations with known exposure should
receive greater attention, concentrating on
the possible association of exposure with
autoimmune symptomology, hypersensi-
tivity, and disease incidence. In wildlife
populations, particularly marine mammals,
analysis must be associative and would
require more rapid and inexpensive meth-
ods to quantify or identify the presence of
EDCs. This will require additional live
capture research on marine mammals using
noninvasive sampling techniques to estab-
lish appropriate baselines of normality.
It is especially important to coordinate
immunological research activities with
reproductive, neurological, and carcinogen-
esis research. The ability to quickly mobi-
lize groups to address environmental prob-
lems, with a tested suite of immunoassays,
would be advantageous when new environ-
mental exposures are detected.
b) Mechanisms: Studies on mechanisms
of action must be conducted for agents that
cause endocrine disruption after initial inter-
action with the immune system. Studies are
also needed that determine the dose level at
which immune effects occur secondary to
endocrine disruption. Exclusive immune
dysfunction at low concentrations would
indicate that the primary target of the
specific EDC would be the immune system.
The endocrine effects caused by many dis-
ruptors have not been examined for
immune system effects. Studies are also
needed to characterize potential effects on
the endocrine system of direct-acting
immunotoxicants. The general feeling was
that many of the endocrine disruptors iden-
tified thus far act directly upon the immune
system; however, the group did not exten-
sively discuss agents that may affect the
immune system via endocrine disruption
(e.g., ammonia).
c) Mixtures: Identification of the
immunotoxic elements within such mix-
tures would be a primary aim, although
more information would be gained if coor-
dinated studies were conducted between
endocrinology, developmental, and neuro-
biology laboratories. In addition, inexpen-
sive analytical tools are needed to analyze
contaminant body burdens. Although
there was some amount of uncertainty in
the group as to the value of bioassays to
grossly quantify classes or groups of EDCs,
this avenue might provide an inexpensive
means of assessing exposure. However,
most samples would be comprised by the
presence of mixture and the contributions
of agonists and antagonists to the EDC
would further complicate analysis.
d) Critical periods: Because studies are
lacking on developmental exposure, they
will have to be conducted in the laborato-
ry, in long-term human epidemiological
studies, or with individually marked
wildlife populations. To date, work with
agents that have an initial impact on the
endocrine system has demonstrated that
the most compelling evidence is related to
developmentally acquired dysfunction.
Furthermore, and perhaps more important,
the effects on the developing immune sys-
tem may be more persistent or longer last-
ing than those that might occur with adult
exposure. The doses needed to elicit these
developmental dysfunctions are not as large
as those for acute exposures of adults; thus,
a much greater percentage of populations
may be affected in this way. For some
wildlife species, studies on normal develop-
mental immunobiology would have to be
conducted prior to any extensive EDC
testing on model species.
e) Sentinel species: The choice of model
or sentinel species for the assessment of
EDC effects on the immune system
requires a great deal of forethought. These
choices should be well suited to answer
specific questions (both of an immunologi-
cal and endocrinological nature). It was felt
that a logical first step might be greatly
expedited by agencies such as the U.S. EPA.
Their access to information concerning the
impact of the environment on populations
throughout the United States could provide
valuable information for determining
potentially good model/sentinel species.
These species should also possess the fol-
lowing characteristics: ease of maintenance
in the laboratory; ubiquitous distribution in
the environment-broad range; accessibili-
ty of large numbers; easily bred within a
laboratory environment (permits analysis of
genetic basis of susceptibility required for
developmental analysis and eliminates
carry-over environmental effects in dose-
response experiments); substantial database
on physiologic parameters; inexpensive cost
of procurement and maintenance; ecologi-
cal relevance; short generation time and
representative of a large number of species
or, at least, groups of species
Upon selection of model species, there
should be coordinated optimization and
standardization of the immunological assays
and their analyses. Major gaps in the endo-
crine and immune databases of selected
species must be addressed immediately.
The entire repertoire of sentinel species
should account for the variety of environ-
mental conditions that may modulate
either the exposure or response to EDCs,
including temperature (if an ectotherm),
trophic level, and other conditions of the
particular niche (i.e., salinity, exposure to
sediment, water column, atmosphere.
f) Ecological monitoring: Studies of
marked wildlife populations are needed
to determine the effects of contaminants
on the demographics and to monitor the
age and accumulation of EDCs within
tissues. Some of the sentinel species used
in these studies need to be relatively
hardy while others may need to be rather
sensitive. For example, trout are often the
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first to disappear from a contaminated site,
thus suggesting the first indication of a
problem. Although this feature in and of
itself may be a good marker attribute for a
sentinel species, it is also advantageous for
the animal to be hardy enough to remain
on the site so sampling can reveal the
nature of the disorders that occur.
What are the highestpriority research needs
for immunologic effects?
The work group agreed that the highest
research priorities should go to areas where
the risk to human and animal life is the
greatest. If the impact is on the immune
system, the risk to life could obviously be
tremendous and would necessitate a com-
mitment to immunotoxicologic research in
this area. However, before such action is
taken, it was felt that the existence of such
problems should be determined by con-
ducting epidemiological analyses of
human, wildlife, and sentinel species, as
described in the previous section. If risk
appears considerable, research should then
be directed toward developmental effects as
well as toward acute effects, and work
should begin as outlined with the most
appropriate sentinel/model species.
Among the highest priority research
needs are
a) Epidemiological studies in both
human and wildlife populations are needed
to establish the incidence of immune-relat-
ed diseases, including immunosuppression,
hypersensitivity, and autoimmunity associ-
ated with exposure to endocrine-disrupting
agents and to determine the impact of
these effects on clinical diseases such as
infections and cancer.
b) Basic research is required to identify
the mechanisms and individual substances
that alter the immune system, and to
determine whether they act directly or
indirectly through alterations of endocrine
system function. Included in this research
should be determination of dose-response
relationships.
c) Methods need to be developed,
particularly for wildlife species, to identify
and validate sensitive assays that detect
immune effects including the selection of
appropriate sentinel species. Included in
this process should be the development
of biomarkers.
d) Studies are needed to determine
whether sensitive populations exist. Based
upon existing evidence, the immunologic
effects of these substances on the very young
(i.e., during the developmental phase) are
of particular concern.
Risk Methodology Issues
Hazard Identification
Hazard identification includes the collec-
tion and evaluation of toxicity data from
test systems, epidemiological studies, case
reports, and field observations. The number
of species evaluated, the number of studies
conducted, the quality of the studies, end
points evaluated, and other factors are
assessed in the context of dosage, route, tim-
ing, and duration of exposure. These data
are used to determine whether the agent in
question poses a hazard, and the context in
which it poses a hazard (i.e., is it route
specific, species specific, life stage specific,
etc.). Discussion focused mainly on prospec-
tive hazard detection, whereas from the eco-
logical perspective, retrospective analysis
related to post-environmental release of con-
taminants is often the more important issue.
This dichotomy was explored further by the
subsequent U.S. EPA-sponsored workshop
devoted to ecological issues (151).
What are the existingguidelines/testingpro-
tocols that evaluate endocrine-related
effects?
Ecological test guidelines. The following
ecological tests are commonly conducted
during the evaluation of industrial chemi-
cals and pesticides. Tests marked with an
asterisk offer the opportunity to detect
effects relevant to endocrine disruption. It
should be noted that the end points of
growth and reproduction measured in
these tests are apical, and hence possibly
reflect effects caused by an underlying
endocrine-linked mechanism. However,
because of this integration, an explicit
endocrine mechanism would not be impli-
cated. The tests include a) short- and long-
term algal toxicity; b) acute and chronic
reproduction* tests in aquatic and terrestri-
al invertebrates; c) acute, chronic*, early
(embryo, larval*) and full life-cycle* tests in
fish; d) acute, 14-day, and longer-term
reproduction studies*, and egg-dosing
studies of hatchabilty and teratology* in
avian species; and e) acute and chronic
effects in plants. Ecological testing uses a
small number of surrogate species to repre-
sent the environment; therefore, the diver-
sity of reproductive and developmental
strategies contained within aquatic and
terrestrial organisms may not be fully
addressed. It was noted that some of these
tests require development of appropriate
positive and negative controls and standard-
ization. Furthermore, they typically do not
address sublethal effects (e.g., hormone
levels, behavior, transgenerational effects
on the offspring) often considered
fundamental in mammalian testing.
Human health testing guidelines.
Various forms of the a) 2-year cancer
bioassay; b) 90-day subchronic toxicity
study; c) multigenerational reproduction
study; d) developmental toxicity study;
e) developmental neurotoxicity tests; and
f) immunotoxicity tests were discussed.
Although these tests are generally used to
evaluate the impact on human health, they
also play a role in assessing effects in mam-
malian wildlife species.
It was the consensus of the work group
that these tests are intended to detect effects,
not to identify mechanisms. For endocrine
disruption, the current tests in many cases
may fail to determine the appropriate no
observed adverse effect level (NOAEL) and
may fail to detect the reproductive toxicity
of estrogenic pesticides [e.g., methoxychlor
(152)]. Implementation of the Harmonized
Reproductive and Developmental Toxicity
Test Guidelines (153) from the U.S. EPA
will improve the ability of these tests
to detect the appropriate NOAELs, includ-
ing those related to endocrine effects.
However, none of the current or proposed
test guidelines require the measurement of
serum hormone levels. In addition, these
tests are poorly designed to evaluate latent
effects that result from exposure early in
life. It was stated by the work group that
the Immunotoxicity and Developmental
Neurotoxicity Test Guidelines were not
specifically designed to detect the effects of
endocrine disruptors on immune function
or CNS development, and, although the
basic two-year cancer bioassay can and does
detect tumors of endocrine organs, transpla-
cental carcinogenesis is not evaluated
because the study design does not include
exposure during critical stages of develop-
ment (i.e., prenatal, neonatal, infantile, and
pubertal stages of life). It was also noted
that current tests generally examine only a
single chemical at a time, which does not
reflect the real world in which exposure is
to complex mixtures of chemicals.
What areas within the present guidelines
need refining and improvingfor the ade-
quate evaluation ofeffects ofendocrine dis-
ruptors?
In light of the previously mentioned short-
comings of the current testing guidelines,
the work group proposed that research be
conducted to develop and validate apical
methods to detect endocrine disruptors.
Once validated, these methods could be
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included in the appropriate test guidelines.
Examples of areas where improvements are
warranted are as follows:
Ecological tests. Because of the lack of an
assessment for transgenerational effects in
ecological tests, a number of additions were
proposed to the current ecological test
guidelines. Research is needed to develop
and validate new testing procedures.
a) Avian reproduction studies should
include an assessment of growth, viability,
fecundity, reproductive morphology, and
behavior in birds exposed in ovo.
b) Some fish species with a short life
cycle may prove to be useful models in
which to examine EDCs in the laboratory.
They can be studied from prefertilization,
through fertilization, hatching, recruitment
into the breeding population, and fecundi-
ty during adulthood. Their hormonal sys-
tems are well characterized and they are
susceptible to hormonally induced cancers.
Assay methods for hormonal systems of
nonmammalian vertebrates need to be vali-
dated and made available to field biologists
on a much larger scale than currently
exists. Additional life-cycle studies for
invertebrates as well as fish are needed to
provide a more holistic hazard assessment
for EDCs.
c) Sexual differentiation studies in inver-
tebrates, fish, reptiles, birds and mammals.
Human health and mammalian tests
(also for other vertebrates, as appropriate).
a) Evaluation of weights, histology, and
hormone production (in vivo with
endocrine challenge tests, or in vitro after in
vivo exposure) of endocrine organs (testis,
ovary, thyroid, adrenal, pituitary, etc.) in
long-term tests [e.g., (154)].
b) Determination of testicular, epididy-
mal, and ejaculated sperm counts.
c) Establishment of landmarks of
puberty and reproductive senescence in
male and female rats and other species.
d) Assessment of sexually dimorphic
behaviors and other CNS functions.
e) Expansion of developmental toxicity
studies to include perinatal exposure and a
postnatal evaluation of reproduction func-
tion of the offspring [i.e., the U.S. EPA
Alternative Reproductive Test (ART) pro-
tocol (155)]. Studies of the effects of
EDCs on sexual differentiation have been
conducted on members of various classes of
vertebrates including, mammals, birds,
fish, and reptiles. Some invertebrate species
have been examined as well. Such proce-
dures could be used to screen chemicals for
EDC activity. While such tests would not
be short term, they would be shorter and
less expensive than the current long-term
rodent studies.
f) Evaluation of the need for transpla-
cental carcinogenesis tests for potent
endocrine disruptors, such as DES and
TCDD, as well as for less potent phytoe-
strogens and synthetic environmental estro-
gens. Examine the utility of short-term tests
to predict developmental carcinogenicity,
including the methods for estrogenic chem-
icals (156-157).
g) Determination whether mixtures of
endocrine-disrupting toxicants act in an
additive or nonadditive fashion at low,
environmentally relevant exposure con-
centrations.
Are there, or can there be, developed, short-
term in vivo and in vitro techniques to
screen toxicants for endocrine disruptor
activity?
While it was acknowledged that the pro-
posed U.S. EPA harmonized test guidelines
would detect many or most EDCs, these
are long-term, expensive studies, and for
these reasons, short-term tests are required
to screen more efficiently the large number
of environmental agents.
Some participants felt that in vitro
methods could be used for such screening.
However, because large numbers of in vitro
tests would be needed due to the plethora
of mechanisms by which EDCs act (i.e.,
altering hormone synthesis, transport,
receptors, metabolism), there was also
strong support for in vivo testing. In addi-
tion, it is not clear how in vitro data could
or would be used in the risk assessment
process. It was noted that when the in vivo
concentration of active moieties of an
EDC in maternal serum reached the Ki
from a receptor binding assay, then all of
the pups would likely be severely mal-
formed. Thus, in vitro data could be used
for risk assessment if additional research
indicates that delivered doses in the range
of the Ki are associated with adverse devel-
opmental effects. It was also noted that in
vitro potency may not correlate well with
in vivo toxicity because of mechanistic and
pharmacokinetic factors. Many experts in
the work group stated that in vivo screen-
ing systems should be implemented, while
others felt that a mixture of in vivo, in
vitro, and QSAR techniques could be used
most efficiently to screen toxicants. It was
pointed out that screening strategies would
vary greatly based on what EDC activity
the regulatory agencies decide to screen for
(i.e., all mechanisms of action versus a lim-
ited subset, like estrogenicity; or all EDCs
versus those that cause developmental alter-
ations). The group recognized that these
issues warrant further discussion within the
scientific community to reconcile the
disparity in opinions. The work group dis-
cussed selected examples of in vivo, in vitro
and QSAR methods that might be
employed to screen for endocrine-disrupting
activity. It was noted that in vivo tests are
often apical while in vitro tests can be more
specific. In vivo tests are more useful if
accompanied by target organ/cell dosimetry
of the biologically active moieties. In vitro
tests also need to determine the actual ver-
sus administered concentration of the
chemical to account for metabolism, stabili-
ty, and solubility. Cellular assays must also
determine cell viability after toxicant
administration. The specificity and limita-
tions of each assay must be clearly defined.
Research is needed to develop and validate
these assays and to define a testing strategy.
Examples of in vivo methods applicable
to the detection of endocrine disruption
include a) rodent models of transplacental
carcinogenesis; b) sexual differentiation
studies in mammals, reptiles, fish, and
birds (in ovo); c) acute and subacute stud-
ies of EDCs on endocrine systems (includ-
ing the hypothalamic-pituitary-gonadal
axis, adrenal and other endocrine axes,
uterine weight and biochemical responses
to estrogens, epididymal and sex accessory
gland function, LH surge and ovulation,
and pregnancy maintenance including in
vitro ovarian and placental steroidogenesis);
d) pubertal alterations induced in male and
female rats by EDCs (including landmarks
of puberty, serum reproductive, adrenal and
thyroid hormones, reproductive organ
weights, histology, and in vitro hormone
production from ovarian, testicular, thyroid
and adrenal tissues); and e) in vivo bioassays
in rodent systems (e.g., uterine weight assay
(157). Clearly, examination is needed of
the rich diversity of species within the ani-
mal kingdom for useful biomarkers of expo-
sure and effect [i.e., vitellogenesis (158)].
Finally, a comprehensive literature search
and further discussion should be conducted
to expand the list of existing in vivo screen-
ing methods used by organizations such as
the the World Health Organization and the
pharmaceutical industry for the detection of
EDCs.
Examples of in vitro methodologies
applicable to detection of endocrine
disruption include a) the MCF-7 cell pro-
liferation assay for estrogen and other
receptors (159); b) competitive receptor
binding assays for estrogens, androgens,
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and progestins (89,160,161); c) transfected
cell assays for hormonal and antihormonal
activity (162-164); and d) in vitro alter-
ations of whole and minced adrenal, ovari-
an, testicular, and placental steroidogenesis
or pituitary and hypothalamic hormone
production [e.g., (165)]. Where possible,
attention should be focused on characteriz-
ing the difference between developing and
adult tissues in these assays.
In addition to direct biological assays,
the work group noted that 3-D QSAR
models are being developed for ligand-
receptor interactions based upon the Ki or
IC50 data derived from androgen, estrogen,
and progesterone competitive binding assays
(166-168). These data are being used as a
training set to develop the QSAR model.
Such models are then tested with chemicals
with known activity, and when validated,
the model can be used to screen libraries of
compounds with unknown activities.
Similar approaches have been successful for
Ah receptor-ligands. Research is needed to
validate and expand the training sets of
these models for the above steroids; similar
efforts need to be initiated for other hor-
mone-receptor interactions. In theory, this
approach could also be expanded to include
toxicant-enzyme interactions. It was noted
that although this technique has incredible
potential utility to screen for EDCs, it can
result in false negatives with chemicals
whose structures lie outside the training set.
Summary of research needs for hazard
identification ofendocrine disruption.
The emphasis for most of the following
research needs is on their application in the
context of identifying the effects of EDCs
in developing organisms. They are
a) Additional validated end points to
supplement current test guidelines and
expand the availability of hormonal assay,
especially for nonmammalian species.
b) Tests and biomarkers to identify
acute and latent effects such as testicular and
prostatic cancer, premature death, shortened
reproductive lifespan, etc.
c) Transplacental toxicology studies for
cancer and noncancer end points.
d) In vivo and in vitro studies of com-
plex mixtures (TEFs for EDCs).
e) Expanded developmental toxicity
studies to include postnatal observations.
f ) Measurement of target organ dosime-
try in vivo to determine if adverse effects can
be predicted from in vitro IC50 or Ki values.
g) Expanded training set data for cur-
rent QSAR models and development of
new models.
h) Correlation of aquatic and wildlife
models with mammalian models.
i) Better coordination of research
among multidisciplinary labs.
j) Improved links between laboratory
and field studies to test hypotheses.
k) Examination of multiple end points
as well as performance of multiple tests on
EDCs.
I) Critical review of additional short-
term in vitro and in vivo tests to screen
EDCs in terms of cost, ease of implemen-
tation, specificity, and limitations.
m) Continued discussion on the devel-
opment of short-term in vitro and in vivo
tests because a complete assessment of
endocrine disruption likely will require
a battery of in vitro and in vivo tests. Such
information will facilitate the use of
mechanistic data in risk assessment.
Dose-Response Assessment
Throughout the discussions on human and
ecological effects of endocrine disruptors,
the workshop participants consistently
agreed that timing of exposure was critical
to the understanding of dose-response
relationships. This is true for the effects of
cancer as well as for the developmental,
reproductive, immunologic, and neurologi-
cal effects. Numerous examples were dis-
cussed, including hormonal influences on
breast cancer where age at exposure is a
known risk factor. Similarly, endocrine dis-
ruption of the developing brain can perma-
nently alter behavior, whereas similar expo-
sures to a fully differentiated brain could be
without effect. Ecological and wildlife
effects are also strongly influenced by the
timing of exposure (e.g., during the breed-
ing season). Research is critical on how tim-
ing of exposure to endocrine disruptors
influences dose-response relationships.
Before addressing the specific questions
presented to the work group, it is worth-
while to review some of the general recom-
mendations targeted at filling knowledge
gaps that create uncertainty in dose-
response evaluations. These overarching
issues include:
a) Risk assessment issues should be
explicitly considered when studies are
designed for health or ecological effects. Of
particular relevance is the issue of dose
selection. Ideally, the doses used should
span a wide range to identify both toxic and
mechanistic end points, and there should
be sufficient numbers of animals and range
of doses to track the various end points.
b) While there may never be complete
knowledge on the mechanism(s) of action
for any chemical, some knowledge on
key events could be sufficient to justify the
use of mechanistic information in dose-
response evaluations.
c) Mechanistic information is most use-
ful when it is linked to adverse outcomes in
cases in which several discrete events (mol-
ecular and biological) are part of the mech-
anism of action. Within technical and eco-
nomic limits, dose-response information
should be obtained on as many relevant
events as possible. Identification of mecha-
nistic information on the rate-limiting
steps in the induction of toxicity is a most
useful outcome of this line of research.
d) Population heterogeneity needs to
be characterized to improve risk assessment
decisions. For human health, a number of
factors contribute to a wide range of risks,
including genetic predisposition, age
(embryos, fetuses, and children are not just
small adults), gender, diet, disease condi-
tions, and past exposures. The range of risk
modulators may be even greater for com-
plex ecosystems but little information is
available in this area.
e) Effects of endocrine disrupters on
ecological and human health have both
distinct and common features. Studies to
identify their common features were
strongly recommended by the dose-
response work group.
f) Evaluation of the health and envi-
ronmental effects of endocrine disruptors
will be most credible when information is
available at several levels such as toxicity,
studies, mechanistic and epidemiological
studies, and field studies. Well-planned
and coordinated multidisciplinary studies
are encouraged.
g) Increased reliance on biology and
mechanisms will create an increased need
to reevaluate potential risks as has occurred
with dioxin.
h) Information exchange systems for
the scientific, regulatory, medical, public
interest, and community sectors need
improvement. The Internet affords an
excellent opportunity to disseminate rele-
vant information to a broad audience.
What are the existing test guidelines and
methodologies used to evaluate endocrine-
related effects? Are there areas within our
present guidelines that need to be refined
and improvedfor the adequate evaluation
of dose-response effects of endocrine
disruptors?
There are no specific guidelines to estimate
dose-response relationships for endocrine
disruptors. Endocrine disruption is inferred
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from results from studies such as those on
cancer or reproduction. The work group felt
that such inferences of endocrine disruption
should lead to experimentation (toxicity,
mechanistic, epidemiological, field studies)
designed to characterize endocrine activity.
General recommendations for experimen-
tal studies. The work group recommended
an aggressive program of improving experi-
mental design that should emphasize
the following:
a) Doses should span a wide range,
including environmentally relevant doses
for human, wildlife, and ecosystem expo-
sures. A sufficient number of doses should
be used to characterize dose-response rela-
tionships for each relevant end point.
b) Studies should quantify and evaluate
multiple end points. End points should be
mechanistic and biological and should be
based on existing knowledge about the
structural properties and effects of the
chemical being studied.
c) End points should be quantified and
linked in the same animal or ecosystem, to
the extent possible, as well as across species
and ecosystems to facilitate the develop-
ment of biologically based models for
estimating dose-response relationships.
d) The use of expanded protocols
should be selective and based on resources,
mechanistic knowledge, and risk assess-
ment needs.
General recommendations for human
studies. The work group felt that there
are opportunities to use existing human
data and to conduct new research to
improve risk assessments for endocrine
disruptors. Specifically, the work group
recommends that
a) Existing records on occupational
and medical exposures to putative and
known endocrine disruptors should be
scrutinized for associations with altered
incidences of adverse health effects.
b) It would be helpful if consensus could
be reached on the most useful questions to
be included during medical examinations.
c) Biomarker studies need to address
comparative responses between experi-
mental systems and humans.
d) Heterogeneity in dose response,
based on genetics, age, gender, and nutri-
tion, needs to be characterized.
Are there unifying dose-response concepts
for endocrine disruptors (i.e., threshold,
linear, sublinear)?
The work group unanimously felt that a
common dose response for all effects and
for all endocrine disruption should not be
expected. This conclusion was based on the
many different kinds of hormonal actions
of chemicals categorized as endocrine dis-
ruptors. These activities include estrogenic,
antiestrogenic, antiandrogenic, growth fac-
tor modulation, cytokine modulation,
modulation of hormone metabolism, and
many others. The conclusion was also
based on the knowledge that there are sev-
eral steps in hormone action and that dif-
ferent environmental agents may intervene
in different processes.
Moreover, there is considerable cell
specificity in hormone action such that the
same hormone and the same receptor can
produce quantitatively and qualitatively
different responses depending on cell type,
age, and other factors. The diverse mecha-
nisms of hormone action are an active area
of research; it appears that factors such as
receptor number, DNA response elements,
signal amplification, desensitization, inter-
actions with transcription factors, ligand
metabolism, and the presence of cellular
agonists could significantly modify dose-
response relationships for any given
endocrine disruptor (169,170).
What are the research needs in the
evaluation ofdose-response relationships?
The work group felt that research on
mechanisms of hormone action could have
spin-off benefits for improving evaluation
of dose-response relationships. For exam-
ple, the sensitivity of cells, tissues, or devel-
opmental stages to an environmental hor-
mone could be predicted with improved
accuracy. Also, it would be helpful to
model common steps in hormone action
such as ligand-receptor interactions
with responsive genes. Additionally, chemi-
cals that share common pharmacologic
properties may share a common response
model. The work group cautions, however,
that endocrine disruption may occur
through mechanisms other than binding to
cellular receptors (i.e., inhibition of
enzymes of steroid hormone metabolism).
The existence of multiple mechanisms both
complicates evaluation of dose-response
relationships and offers opportunities to
better predict low-dose effects for different
kinds of mechanisms of endocrine disrup-
tion. In addition to studies of known recep-
tors, there may be unknown receptors,
including orphan receptors, on which new
research is needed.
There was considerable discussion of
knowledge gaps in mechanisms of hor-
mone action, as these gaps create uncer-
tainty in the evaluation of dose-response
relationships for endocrine disruptors.
Although a great deal is known about the
initial steps in hormone action such as
binding to receptors and transcriptional
activation of responsive genes, very little is
known about how those changes in gene
expression lead to biological effects such as
cell proliferation. This lessens the credibility
of biologically based models for predicting
dose-response relationships for endocrine
disruptors. However, several work group
members felt that such models still repre-
sent an improvement over the default
approaches currently used in risk assess-
ments. For example, it may be possible to
compare potencies of chemicals apparently
acting through common mechanisms (i.e.,
binding to a specific receptor) and to better
predict targets or potentially sensitive cells
or tissues. It is also important to distin-
guish steps in the mechanism that can alter
the slope of the dose-response curve,
potency, or target organ specificity.
The role of interactions between
endogenous and exogenous hormones was
discussed. This led to the recommendation
that baseline data on endogenous hor-
mones, including cyclicity and differences
in tissue concentrations, are needed not
only to improve the ability to predict the
environmental or health consequences of
endocrine disruptors but also as input into
mathematical models of development and
endocrine system function.
Finally, issues related to the dose-
response assessment of mixtures were
addressed. Considerable debate exists
regarding about dose-response relation-
ships for single compounds even when a
reasonable amount of toxicologic data is
available. Yet humans and ecosystems are
exposed to a vast array of chemicals that
may interact by potentiation, synergism,
inhibition, and antagonism of toxic effects.
Although progress will be slow in risk
assessment of mixtures, the following
recommendations were developed:
a) Include environmentally relevant
doses and ratios of chemicals in ecological,
wildlife, and experimental animal studies
b) Use the knowledge of mechanisms
and appropriate biomarkers (sensitive and
specific) to dissect major contributors to
toxicity
c) Determine the pharmacokinetics of
toxic chemicals, within mixtures, and the
dose at target tissue
d) Improve TEF estimates for environ-
mental agents that interact with specific
endogenous receptors (e.g., Ah and estrogen
receptor ligands) by systematically testing
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assumptions inherent to the TEQ approach.
These assumptions include the similarity of
mechanism and the role of persistence and
accumulation. The work group also felt that
TEF estimates would be improved by care-
ful selection of experimental systems used to
determine relative potencies and the use of
appropriate dose ranges, including low doses
to separate direct from indirect effects on
the endocrine system.
Are there particular elements to be
considered in dose-response evaluation
in wildlife species?
The work group felt that evaluation of
dose-response relationships to assess ecosys-
tem and wildlife effects will be extremely
difficult but would benefit by implementa-
tion of the following considerations:
a) Improved understanding of the fac-
tors, such as genetic diversity, that are
critical to the maintenance of integrated
ecosystems. It will be difficult to character-
ize dose-response relationships without
improved knowledge of normal fluctuations
in ecosystem constituents.
b) Laboratory and field studies need to
be better coordinated. In addition, better
definition is needed of what constitutes
field validation of a laboratory finding as
well as laboratory verification of an effect
observed in the field.
c) Guidelines need to be developed for
selection of sentinel species and evaluation
of dose-response relationships. Guidelines
for dose-response assessment should be
general and not overly prescriptive.
Is itfeasible to develop complete biologically
based dose-response models for endocrine
disruptors?
The work group encouraged the develop-
ment of biomathematical models for
endocrine systems, recognizing that there
will not be a single model applicable to all
hormones. However, the shared steps for
some systems (e.g., hormone receptor bind-
ing) could be modeled using the same set of
equations. These models should incorpo-
rate data from humans, rodents, and the
ecological species. Development of these
models must include time dependence of
hormonal action.
Statistical and mathematical models for
toxic end points such as cancer, reproduc-
tion, or development should be helpful in
identifying knowledge gaps that create
uncertainty in dose-response estimates and,
in this way, can focus available resources in
the most productive way. These efforts will
require increased resources for fostering the
multidisciplinary research needed for the
development of models for health and
environmental effects. Establishing cross-
disciplinary programs for mathematical
and simulation training for biologists and
biological training for statisticians and
mathematicians would enhance the credi-
bility of biologically based models for
endocrine disruptors.
Exposure Assessment
What chemicals in the environment are of
concernfor endocrine disruption?
The work group agreed that developing a
comprehensive list of putative endocrine
disruptors would take longer than the time
available at the workshop. Any list so con-
structed would not be entirely accurate or
comprehensive at this time. Nonetheless,
from the viewpoint of exposure assess-
ment, it was agreed that EDCs should be
categorized as follows:
Use pattern-for example, herbicides,
insecticides, fungicides, hormones, etc.
Chemical structure or class-for
example, dioxins, halogenated biphenyls,
alkyloxyphenols, etc.
Biological function and mechanism of
action-for example, estrogen mimic,
androgen inhibitor, etc.
What do we know about the status and
trends ofputativeEDC?
The initial discussion focused on what we
know and what we need to know about the
status and trends of putative EDCs.
Environmental and tissue levels of some
EDCs, such as DDT and its analogs, and
PCBs, have declined in some countries and
in most areas of the United States in
response to regulation (171-178). Uncer-
tainty still exists regarding future trends of
these compounds, however, because of off-
shore inputs and releases from stored mate-
rials. It also appears that for many EDCs,
the environmental concentrations that
declined from the mid-1970s through the
early 1980s have now reached a plateau
(179,180). This is a cause for concern. For
most other EDCs, particularly new chemi-
cals or chemicals that have not been rou-
tinely monitored, the trends are unknown.
The information needs regarding status
and trends of EDCs are considerable. A
better understanding is needed of the fate
and transport of new and existing chemi-
cals, particularly among the different envi-
ronmental compartments (water, sediment,
biota). Key concerns have been raised about
air and water serving as transport media
and exposure routes for EDCs for both
humans and wildlife. The importance of
water use practices and how they impact
on exposure must be more thoroughly
investigated. Water use practices that con-
tribute to EDC exposure, such as agricul-
ture, sewage discharge, unfinished waters,
and unregulated drinking water sources,
require review. Any research on water use
must consider factors that affect flow and
dilution such as season, diversion, and
regulated release of impounded waters.
Exposure assessment, particularly as it
involves human health, must focus on vul-
nerable groups, both in terms of life stage
and lifestyle. Exposure assessment for the
critical development stages is a high
research priority. This includes pregnancy,
gestation, lactation, adolescence, and senes-
cence. Vulnerability of different groups in
the population will be affected by lifestyle
factors such as subsistence hunting and
fishing and avid sportsmen who consume
fish and wildlife, or host factors such as
metabolic differences among polymorphic
groups, special dietary habits, and age (e.g.,
the types and rates of food consumption in
children). While the work group agreed
that diet would likely be the major exposure
route, an approach based on integrated
exposure assessment needs to be taken. All
routes should be examined (e.g., dermal,
inhalation, and ingestion). The work group
stressed the importance of a global perspec-
tive on exposure. EDCs that may have
restricted or no use in the United States are
still used in other countries and may become
sources of exposure through either imported
food or atmospheric transport and deposi-
tion. Further, the potential for human or
wildlife exposure to multiple chemicals that
may function as EDCs should be included
in any exposure assessment.
The most critical need on status and
trends is for the continuation and improve-
ment of monitoring of the environment for
the presence and magnitude of contami-
nants. Existing programs that furnish
repeated measures of chemical contamina-
tion in the environment or in food provide
our only indication of whether exposure is
increasing or decreasing, and to what mag-
nitude. Therefore, the work group strongly
recommended continuation of existing
programs such as the National Human
Health and Nutrition Examination Survey
(NHANES) (181); the National Human
Exposure Assessment Survey (NHEXAS)
(182); the Market Basket Analysis of the
U.S. Food and Drug Administration; the
Pesticide Data Program of the U.S.
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Department of Agriculture; the National
Contaminant Biomonitoring Program of the
National Bureau of Standards (173,183);
and the NOAA Status and Trends Program
(184). Existing international monitoring
efforts must be continued. For new pro-
grams or for improving existing programs,
the work group felt analytical expenses
could be reduced through specificity of
analysis. Where markers or bioassays are
able to replace chemical analysis, they
should be used, and analytes should be tar-
geted to meet the specific monitoring need
of the designed program.
More research needs to be focused on
development and validation of monitoring
tools. Current results with caged organisms
have been successful because they provide
biologic relevance to the estimation of expo-
sure. Despite the drawbacks inherent in
using caged organisms, such as stress associ-
ated with captivity and the absence of expo-
sure during the sensitive reproductive and
developmental stages, the work group felt
this tool warranted further development.
Research also should continue on other
monitoring tools such as in situ samplers
that mimic biological tissue, or assays used
with field grab samples. As field tools to
measure exposure assessment become more
available, concurrent research in toxicity
identification evaluation (TIE) procedures
(185) must occur to enable verification of
causative agents.
What are the assumptions in estimating
exposure to endocrine disruptors?
Valid exposure assessment requires that cer-
tain assumptions be either accepted or
proven. The work group assumed that envi-
ronmental concentrations did not equate to
exposure because of several factors. Activity
patterns such as migratory behavior, bioavail-
ability of compounds, and lifecycle stage are
examples of factors that limit the use of envi-
ronmental concentrations. Body burdens
may be much better indicators of exposure,
especially for persistent chemicals, but they
also may vary seasonally and with age (186).
However, research is needed to develop tis-
sue-specific body burdens and determine
how they translate to specific dose. This will
require full understanding of the physiology
and toxicokinetics of the compound and its
host. Assessing bioavailability is complicated
by transplacental boundaries, interaction
with transport molecules, and matrix binding
(e.g., sediment particles, dissolved organic
carbon) and should be a focus of research.
Another critical assumption can be
made based on knowledge of the actions of
EDCs; that is, a population of breeding
adults with apparently healthy offspring, or
young in the population does not necessar-
ily indicate health. The ability of some
EDCs to evoke transgenerational effects
requires a more in-depth look at the health
of a population. Reproductive capacity and
normal reproductive functioning of the
offspring may be the most sensitive test of
population health. Research is needed to
develop preclinical indicators of transgen-
erational impacts so that they can be linked
to strategies that limit or eliminate exposure.
To what degree can body burdens in the
generalpopulations ofhumans and wildlife
be identified by exposure or hostfactors?
One of the research needs that was
identified and given the highest priority was
the further development and validation of
indicators of exposure to EDCs. Whether
these indicators are biomarkers or bioassays,
they must be sensitive and specific to both
persistent and nonpersistent compounds.
These indicators must be validated on a
species-by-species basis. Examples of some
measures that have been applied include
vitellogenin production in male fish
(158,187) and induction of cytochrome
P450 (188), although in both instances,
lack of response does not necessarily equate
to lack of exposure.
In addition to bioindicators, other
indices that may be termed population mea-
sures need to be applied to EDC exposure.
Sperm counts, sex ratios, and incidence of a
specific tumor or abnormality are examples
(74,189-191). If these prove to be indices
of effect, changes in these population mea-
sures could be used to identify populations
potentially exposed to EDCs. Exposure
indicators then could be used to quantify
the dose-response relationship. The work
group proposed a scenario in which indica-
tors could be used in a tiered hierarchy that
would demonstrate evidence of exposure to
EDCs; clarification of the mechanism of
effect (e.g., estrogen mimic, androgen
inhibitor); and TIE methods to identify
responsible compounds. Given these needs,
indicators should be sensitive at ambient
levels of contamination and specific to
chemicals and end points that would enable
identification of mechanism of action.
Are there specific confounding factors or
temporalpatterns ofeposure to be consid-
ered in the assessment ofpublk and wildlfe
health implications ofendocrine disruptors?
Estimating the exposure of humans and
wildlife to potential EDCs creates a unique
set of confounding factors. While this list is
certainly not comprehensive, the work group
identified the following significant factors:
a) Time lags between exposure and
effect: The transgenerational nature of
some EDC effects may be the single most
complicating factor. All of the potential
latent effects that may occur from short-
term exposures during critical developmen-
tal windows have not yet been identified.
b) Seasonality: Because of the sensitivi-
ty of reproductive stages to EDCs, season-
ality will be extremely important to wildlife.
In addition, the association of EDCs with
the aquatic environment is complicated by
seasonal rainfall, storm runoff, and water
releases.
c) Species variability: Perhaps this is no
more important for EDC exposure than
with any other toxicant effect. However,
the work group particularly stressed that
more basic research is needed on general
endocrine physiology of target species.
d) Multiple chemical exposures: This,
too, is a confounding factor for any toxi-
cant. It is especially identified here because
of the potential for joint toxic action and
the presence of naturally occurring
phytoestrogens.
A comprehensive list would identify a
number of general confounding factors such
as past exposure history, occupational expo-
sures, nutritional status, trophic structure
and other relevant factors.
Summary of research needs for exposure
assessment.
A number of research needs were identified
in the previous section. The following list
was deemed to be of the highest priority:
a) Monitoring: Maintain and increase
monitoring efforts that help identify status
and trends of EDCs, including chemical
monitoring programs and population mea-
sures such as wildlife reproductive success,
sperm count studies, etc. These programs
are critical to the identification of popula-
tions at risk.
b) Biomarkers: Develop and validate
biological indices for use as screening tools.
More biomarkers, bioassays, and popula-
tion measures are needed that are sensitive
at relevant environmental concentrations
and are mechanism specific.
c) Exposure hierarchies: Develop an
applied, integrative iterative hierarchy of
exposure indicators. Components should
range from screening level tests to much
more predictive indicators. This approach
should be designed to avoid false negatives
in initial tiers and progress in final tiers to
Environmental Health Perspectives * Vol 104, Supplement 4 * August 1996732
ENDOCRINE DISRUPTOR RESEARCH NEEDS
more predictive indicators that are linked
to effects.
Risk Characterizaton
The National Academy of Sciences' Risk
Assessment paradigm was used as a tool to
identify research needs. In this case, the
approach had limited success since the
majority of the group members had limited
experience with the specific composition of
a risk characterization. The work group,
however, did identify several major points
for which there was broad agreement.
Normal functioning of the endocrine
system encompasses a wide fluctuation of
hormone and other biological indices,
which reflect among other things, circadi-
an rhythm, season (temperature, light),
age, and gender. For example, concentra-
tion extremes of sex hormones occur at
specified times for normal physiologic func-
tions; such periods include sexual differ-
entiation, puberty, reproductive cycles, par-
turition, lactation, and menopause. The
presence and magnitude of certain hor-
mones are critical to normal ontogenic
development, including some neurobehav-
ioral programming, in a broad range of
biota that include insects and other inver-
tebrates, amphibia, reptiles, fish, birds,
and mammals. Studies in wildlife and in
the laboratory have demonstrated that
certain chemicals may perturb specific
endocrine functions at specified periods
during the life span. The consequences of
exposure during these windows of sensi-
tivity may manifest themselves at later
periods of life. To better understand and
predict specific circumstances under
which adverse effects may occur, it is
essential that there be better identification
and characterization of these critical expo-
sure windows. The homology of these sen-
sitive periods across species is also impor-
tant for accurate risk prediction.
To understand the nature and degree to
which an adverse effect reflects response to
a nonendogenous chemical with endocrine
properties or alters the type and magnitude
of endogenous hormones often requires
consideration of a broad range of biologic
interactions. For example, the role of agents
from environmental sources such as phy-
toestrogens or estrogenic products from
fungi should be considered. It was recom-
mended that the current literature on phy-
toestrogens be reviewed as a prerequisite
for determining additional data needs in
this area. A comprehensive bibliography
for phytoestrogens is available on the
Internet (unpublished data).
The traditional risk assessment para-
digm can be used to adequately identify and
characterize chemicals that cause adverse
effects by altering endocrine processes.
However, the assessment paradigm should
be tailored to permit consideration of such
factors as normal fluctuations of endoge-
nous levels of hormones, impact of other
agents (phytoestrogens), the existence of
critical windows of sensitivity, and the need
to understand the significance of subtle
effects at low doses. In other words, dose
effect may need to be expressed in several
contexts such as adult effects, adult dose
effect in a particular physiologic state (such
as immediately postpartum or during lacta-
tion), or at a particular window of sensitivity
for causing developmental toxicity.
Endocrine effects often occur subse-
quent to receptor-ligand binding. A variety
of agents may interact with a binding site
acting as agonists, partial agonists, or antag-
onists. Since exposures may entail simulta-
neous interaction with various endogenous
and exogenous substances, it is critical that
receptor theory be used to develop or refine
quantitative models for estimating the
effects of such exposures.
The limited utility, to date, of SAR to
predict biological effect for estrogenic
agents was noted. Perhaps a useful criterion
for screening EDCs for more robust study
is whether they can elicit (or inhibit in the
case of antagonists) a transcriptional event.
Such a criterion would only serve to screen
out agents; agents that met this sort of func-
tional definition would still need to be char-
acterized before determining if they have
actual toxicological potential. However,
such tests would still be limited in their
abilities to detect the action of metabolites.
The presumed receptor-based mecha-
nisms, responsible for at least some adverse
endocrine-modulated effects, present a
unique opportunity to establish a common
biologically relevant risk assessment process
for all effects, i.e., developmental, immuno-
logic, neurological, and carcinogenic
effects. The group is not aware of a biolog-
ical basis for selecting different models to
quantitatively estimate cancer or non-
cancer effects for chemicals that act by
endocrine-mediated mechanisms.
Summary Recommendations
The majority of the participants at the
workshop agreed that the endocrine dis-
ruptor hypothesis was of sufficient concern
to warrant a concerted research effort. In
particular, the study of potential effects on
the development of reproductive capability
at multiple phylogenetic levels was deemed
the most important area in need of atten-
tion. It was repeatedly emphasized that the
developing embryo, fetus, and neonate
should not be viewed as small adults and
that the processes of development are
especially vulnerable to brief periods of
endocrine disruption. However, for many
of the effects reported in both wildlife and
humans that have been attributed to, or
associated with, endocrine disruption, expo-
sure assessment has generally been inade-
quate for quantitative risk assessment.
Because of this, some participants felt it was
difficult to critically evaluate and establish
the level of priority relative to other research
topics. Still other participants reminded the
work group not to lose sight of the presence
of naturally occurring endocrine disruptors
(e.g., phytoestrogens) as the effects of man-
made chemicals are studied.
Several general comments emanated
from the discussions. These include the
recognition that there was a great advan-
tage in bringing together a multidiscipli-
nary group of scientists representing both
the human health and ecological health
viewpoints to help identify common issues
and that this interaction must be nurtured
as the research agenda unfolds. The work
group noted that some key similarities and
differences exist between endocrine disrup-
tors and other chemicals that can cause
adverse biological effects. Two of the key
differences are the presence of natural lig-
ands within the body that must interact at
some level with the exogenous chemical;
and that the concentrations of the natural
ligands within the body fluctuate during
the life cycle and must be maintained with-
in narrow limits at key times during devel-
opment. This latter point indicates that
timing of exposure is a very significant fac-
tor in any assessment. Last, the mechanistic
basis of the interaction with biological sys-
tems presages the induction of subtle
effects at low doses that must be interpreted
as to whether or not the effects are adverse.
As the level of organization at which bio-
logic responses to endocrine disruptors are
observed decreases (e.g., from physiologic
to cellular to molecular), the challenge to
describe the effects as adverse at the level of
the individual and the population increases.
In this regard, endocrine disruptors are not
unlike other types of chemicals for which
toxicologic information is amassed.
In general, it was felt that linking
specific exposures to specific effects in the
general environment would often be diffi-
cult because of the complexities of exposure,
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the latency of the effects, and, at times, the
subtle nature of the outcomes. Therefore,
confirmation of the validity of the hypoth-
esis will rely heavily on application of the
Hill criteria (192,193) for causality
(strength of the association, presence of a
dose-response relationship, specificity of
the association, consistency across studies,
biological plausibility, and coherence of the
evidence). Such considerations will have
significant impact on the types of research
activities necessary to adequately confirm
or refute the central hypothesis. A compos-
ite representation of the identified needs is
provided in Table 2. Ten broad categories
of research needs were identified: basic
research, biomarkers, database develop-
ment, exposure determination, exposure
follow-up, hazard identification, mixtures,
multidisciplinary studies, risk assessment
models, and sentinel species. Within
each of these categories, the work groups
that identified each need are indicated.
The neurological, immunological and
carcinogenic work groups all noted the
complexity of identifying whether effects of
xenobiotics on those systems were the
result of primary or secondary aspects of
endocrine disruption. This concept is
developed in Figure 1, which portrays not
only the interaction between the endocrine
system and the target organs but also the
interactions among the target organs them-
selves. For these reasons, identifying agents
as direct or indirect endocrine disruptors is
problematic, and necessitates research to
Table 2. Composite research needs identified by the eight work groups.
Research area Work group origina Research need
Basic research R, N, 1, DR
Biomarkers
Database development
Exposure determination
Exposure follow-up
Hazard identification
Mixtures
Multidisciplinary studies
Risk assessment models
Sentinel species
R
C
R, N, DR
DR, RC
RC
DR
C, R, N, /, DR
EX
HD
R
HD
R
R
C
C
EX
C, R, N, I
HD
R, HD
RC
R, HD
N, 1, HD
N
R, HD, DR
R, I,DR
C
N
R, HD, DR
HD
N, I,DR
HD
R
DR
EX
C, DR
N
DR, RC
DR
C, N, /, DR
C
Understanding the cellular and molecular mechanisms, including nonreceptor mechanisms, for EDCs
Sensitive, inexpensive, and widely available analytical tools
Animal and cellular models of endocrine-mediated tumors
Ontogeny of receptor-based systems and role in regulating development
Understanding of the mechanisms and biological significance of subtle low-dose effects
Identify and characterize critical windows of susceptibility across species
Characterize source of population heterogeneity in responsiveness (age, gender, nutrition, etc.)
Development of biomarkers of exposure and effects of EDCs
Develop and validate biological indices as screening tools for exposure assessment
Development of biomarkers for latent effects
Information on normal population variation, regionnal, and seasonal effects
Critical review of short-term tests for EDCs
Prospective and retrospective reproductive health trends
Field data on hormone levels, body burdens, and gene expression markers
Systematic potency comparison of endogenous versus exogenous substances
Surveillance systems for cancer incidence and mortality in wildlife
Rapid and inexpensive exposure monitoring methods for use in wildlife populations
Increased monitoring efforts to identify status and trends of EDCs
Multidisciplinary teams to study exposed populations
Autoimmune symptomology, hypersensitivity, and disease in EDC-exposed humans
Coordinated research on exposed humans, wildlife, and sentinel species
Target organ dosimetry for comparison with ligad-binding affinities
Expanded development of QSAR models for hazard detection and ranking
Identification of transcriptional events after ligand binding as QSAR input
Development and validation of apical methods to detect EDCs
Perinatal and multigenerational exposure toxicity studies for cancer and noncancer effects
Research to address the additivity principle for mixtures
In vitro and in vivo studies of complex mixtures to evaluate validity of TEFs
Identification and testing of environmentally relevant mixtures
Systematic evaluation of species-, cellular-, and age-dependent response to mixtures of EDCs
Systematic field and laboratory studies focused on critical uncertainties
Laboratory-field hypothesis-based studies and improved information exchange
Examination of correlation of effects between wildlife and mammalian models
Multidisciplinary studies on effects of endocrine disruption
Examination of multiple end points and multiple tests of ED action
Statistical models to predict risk from exposure and effects
Improvements in study design (dose selection, end points, end point linkages)
Development of applied integrative iterative hierarchy of exposure indicators
Evaluation of toxicity and mechanistic end points across species common steps and chemical classes)
Toxicokinetics and toxicodynamic studies of environmentally relevant chemicals
Quantitative dose-response models based upon receptor theory and biochemical interactions
Establishment of training programs in biomathematics for BBDR model construction
Identification and monitoring of differentially susceptible sentinel species
Cancer studies in domestic animals and pets
Environmental Health Perspectives * Vol 104, Supplement 4 * August 1996
"BBDR, biologically based dose-response model; C, carcinogenesis; R, reproductive toxicity; N, neurotoxicity; 1, immunotoxicity; HD, hazard detection; DR, dose response; EX,
exposure assessment; RC, risk characterization. Designations in bold and italics were among the highest priority needs identified by the respective work groups. In general,
carcinogenic and reproductive studies were considered to be higher priorities for biological effects research, while exposure assessment was a recognized deficiency in most
population studies.
734
ENDOCRINE DISRUPTOR RESEARCH NEEDS
carefully define dose-response relationships
across multiple end points, to delineate the
proximate mechanism of action, and to
ascertain the complete organismal response
to an environmental exposure. However,
in terms of protection of human or wildlife
populations, it is less important to deter-
mine whether effects are primary or
secondary once they are observed in the
general environment.
Workshop participants were in general
agreement that the highest priorities for
biologic effect research lie in the areas of
development of reproductive capability
and carcinogenesis, as these end points
have had greater documentation of being
adversely affected by alterations in
endocrine function than have either the
nervous or immune system. However, the
incidence of effects on the nervous and
immune systems may be underestimated
at this point because of incomplete
characterization of the biologic effects of
endocrine disruptors. In addition, it
should be noted that many reproductive
effects, especially those involving a behav-
ioral component, are mediated by effects
on neuroendocrine function. In particular,
identification and characterization of
effects on the developing reproductive sys-
tem were considered to be high priority
for additional research because of the high
sensitivity and frequent irreversibility of
effects after even brief exposures. More
refined exposure assessments and research
on the toxicology of mixtures were also
considered to be of great importance.
Special emphasis was placed on the unique
challenges endocrine disruptors might
pose to the risk assessment paradigm.
Interestingly, understanding the basic
mechanisms of endocrine disruption
induced by various chemicals was seen as
an advantage in that this knowledge may
result in a common, biologically based,
risk assessment process for all effects (i.e.,
both cancer and noncancer).
At least three outcomes are expected
from the workshop. The first of these is
the publication of this report in the
scientific literature so that it is readily
available to both researchers and the pub-
lic. Second, within the U.S. EPA, the
Office of Research and Development in
conjunction with input from the Program
Offices will be developing an augmented
research initiative beginning in Fiscal Year
1996 to implement some of the recom-
mendations of the workshop. To assist in
further focusing the research needs for
endocrine disruptors for research support-
ed by the U.S. EPA, a workshop on ecolog-
ical research needs was held in Duluth,
Minnesota, in June 1995 (151). Persons
seeking information from that effort
should contact Dr. Gary Ankley of the
MED/NHEERL/USEPA in Duluth.
Finally, an Endocrine Disruptor Research
Coordination Workshop has been formed
under the auspices of the National Science
and Technology Council that will a) devel-
op a federal research strategy that addresses
the key scientific uncertainties for
endocrine disruptors, b) inventory related
ongoing federal research efforts, c) identify
research gaps between ongoing research
programs and needs identified in the strate-
gic plan, and facilitate cooordination and
cooperation across the federal government
to address them, d) initiate outreach
efforts to engage public interest, private
sector, and international groups with inter-
est in this issue, and e) promote education-
al activities such as symposia and work-
shops to disseminate endocrine disruptor
information across the scientific communi-
ty. Persons wishing to find out more about
this effort should contact the senior author
of this report.
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